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ABSTRACT OF DISSERTATION 
 
 
A WHOLE CELL BASED BIOSENSOR FOR MONITORING PHYSIOLOGICAL 
TOXINS AND EARLY SCREENING OF CANCER 
 
Recently a whole cell based biosensor has been developed in our laboratory that 
consists of a monolayer of human umbilical vein endothelial cells (HUVECs) on the 
asymmetric cellulose triacetate (CTA) membrane of an ion selective electrode (ISE). 
When a confluent cell monolayer is formed across the membrane, response from the 
sensor is inhibited due to inhibited ion transport across the membrane. When the cell 
based biosensor is exposed to permeability modifying agents, the permeability across the 
cell monolayer is altered facilitating more ion transport and as a result the response from 
the sensor increases. This sensor response can be related to the concentration of these 
agents. One objective of this research was to investigate the ability of the sensor to detect 
a physiological toxin, alpha toxin from Staphylococcus aureus. Studies demonstrated that 
the biosensor can detect 0.1ng/ml alpha toxin. Considering the fact that the concentration 
of this toxin is 100-250 ng/ml in whole blood in humans, this biosensor has the ability to 
act as the diagnostic tool for staphylococcal diseases. Another part of this research was to 
investigate the ability of the biosensor to measure angiogenesis by measuring the changes 
in permeability induced by cytokines such as vascular endothelial growth factor (VEGF), 
basic fibroblast growth factor (bFGF), hepatocyte growth factor (HGF) and tumor 
necrosis factor –α (TNF- α) individually and in combination. The sensor response was 
then compared with the common in vitro assays for angiogenesis. The study 
demonstrated that at the concentrations studied the sensor response in the presence of 
cytokines was much higher than that observed for other angiogenesis assays, thereby 
bolstering the potential of the biosensor to act as a quick screening tool for angiogenesis. 
Furthermore, epithelial cell based sensor responses to the same cytokines were compared 
with the responses from endothelial cell based sensor and the mechanisms behind the 
increased sensor response were elucidated. Finally, to investigate the ability of the sensor 
to screen cancer, the biosensor was exposed to the serum from healthy individuals and 
cancer patients. The results showed that the sensor can distinguish between healthy 
individuals and cancer patients and the results correlate with the stages of cancer. 
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 1 
Chapter 1 : Introduction 
 
A sensor consists of a recognizing element which responds to the analytes being 
measured and a transducer which converts the observed change into a measurable signal. 
In the case of a biosensor, the recognition system is a biological element, living 
organisms or components of living organisms. Thus, a blood-oxygen sensor is not a 
biosensor even though it is measuring a biologically important parameter; but is a 
chemical sensor that has biomedical applications (Harsanyi 2001). On the other hand, a 
microorganism based sensor, detecting heavy metals in industrial effluent, is a biosensor 
simply because the recognizing unit is a biological element. In the last two decades, 
tremendous growth in research related to biosensors has been observed with the 
applications extending to the food and agriculture industry, medical, environmental as 
well as in military fields.  
 Currently, there exits a need for simple, reliable yet less expensive devices which 
can act as physiological detection tools. Recently a whole cell based biosensor, had been 
developed in our laboratory, which takes advantage of cell-barrier dysfunction to detect 
the presence of small quantities of permeability modifying agents. The biosensor 
incorporates a monolayer of human umbilical vein endothelial cells (HUVECs) on the 
asymmetric cellulose triacetate (CTA) membrane of an ion-selective electrode (ISE). The 
presence of a confluent monolayer of cells inhibits the transport of ions to the membrane 
surface resulting in an inhibited response from the sensor. When the permeability across 
the cell monolayer is altered by exposing the cell based sensor to these permeability 
modifying agents, the response from the sensor increases. The response thus obtained can 
then be related to the concentration of these agents. Earlier studies have shown that the 
endothelial cell based sensor can detect the presence of histamine and VEGF (May et al. 
2005; May et al. 2004a) 
 The overall goal of this research was to investigate the use of the whole cell based 
biosensor for detecting physiological toxins as well as for early screening of cancer. 
Specifically, the biosensor has been used to detect the presence of staphylococcal alpha 
toxin. Staphylococcus aureus is one of the most common pathogens in a nosocomial 
setting. Alpha toxin, a protein exotoxin produced by the majority (85-90%) of S. aureus 
 2 
strains (Mollby 1983), plays a critical factor in S. aureus induced pathogenicity. The 
biosensor was also used to measure permeability changes induced by different cytokines 
such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), 
hepatocyte growth factor (HGF) and tumor necrosis factor – α (TNF-α), as an alternate 
assay for measuring angiogenesis.  Angiogenesis, sprouting of new blood vessels from 
existing vasculature, is observed in several diseases such as cancer, arthritis and diabetes. 
In cancer, angiogenesis occurs during the early phase of cancer, leading to the release of 
elevated concentrations of different cytokines in the blood of cancer patients as compared 
to healthy individuals (Dirix et al. 1997; Sezer et al. 2001). Based on the hypothesis that 
any device that can measure angiogenesis can act as a quick screening tool for cancer, the 
responses of the biosensor to the serum samples from healthy individuals and cancer 
patients (different origin and stages) were measured to determine the ability of the sensor 
to screen cancer. Since permeability across an epithelial cell monolayer is altered by 
different cytokines, LLC-PK1, porcine kidney epithelial cells were also seeded on ISE 
membranes surface, and the response of the sensor to the presence of the cytokines was 
measured. Moreover, studies were also conducted to elucidate the mechanism behind the 
increased permeability induced by different cytokines across HUVEC and LLC-PK1 
monolayers. 
Specific objectives of the research include: 
 To investigate the use of the HUVEC based biosensor for detecting 
staphylococcal alpha toxin, a toxin involved in various infections including 
septicemia, endocardytis, septic arthritis, etc. 
 To investigate the use of the HUVEC based biosensor for assaying angiogenesis 
and to compare the responses of the sensor to the responses obtained from 
common in-vitro angiogenesis assays. 
 To investigate the ability of a porcine epithelial cell, LLC-PK1, based sensor to 
detect the presence of cytokines. 
 To study the mechanisms involved in altering permeability of HUVEC and LLC-
PK1 monolayers. 
 To investigate the ability of the HUVEC based sensor to act as a screening tool 
for cancer. 
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In Chapter 2, a general background on biosensors and ISEs is given. The general 
materials and methods employed for culturing HUVECs and LLC-PK1s as well as for 
fabricating the asymmetric membranes for the biosensor and evaluating the responses are 
discussed in Chapter 3. Chapter 4 discusses the study involving the effect of 
staphylococcal alpha toxin on sensor response as well as on HUVEC morphology. 
Moreover, the detection limit of the biosensor is determined and the correlation obtained 
between the sensor response and intercellular gap formation evaluated. To study the 
ability of the biosensor to measure angiogenesis, the effect of different cytokines, 
vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), 
hepatocyte growth factor (HGF) and tumor necrosis factor – α (TNF- α), individually and 
in combination, on the biosensor response is evaluated in Chapter 5. The responses thus 
obtained are compared with the responses obtained from common in-vitro   angiogenesis 
assays. Since cytokines also alter the permeability of epithelial cells, the effect of VEGF, 
HGF, bFGF and TNF- α on a LLC-PK1 cell-based biosensor response is discussed in 
Chapter 6. Moreover, the mechanisms involved behind the altered permeability across 
HUVEC and LLC-PK1 monolayer have also been elucidated. Furthermore, the effect of 
these cytokines on the cell-matrix adhesion has also been discussed. Chapter 7 discusses 
the responses obtained from the biosensor upon exposing it to the serum samples from 
healthy individuals as well as cancer patients. The responses have been studied as a 
function of cancer types as well as stages of cancer. Chapter 8 summarizes the results of 
the current studies. The aspects of future studies have been discussed in Chapter 9. 
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Chapter 2 : Background 
 
2.1  Biosensors 
Biosensors consist of a biological sensing/recognition system connected to a transducer. 
The biological element, which consists of living organisms or components of living 
organisms, interacts with the substrates/analytes and then the transducer converts the 
observed change into a measurable signal. The magnitude of this signal is related to the 
concentration of the analytes. A schematic diagram of a biosensor is shown in Figure 2.1. 
Over the past two decades biosensors have been increasingly used in environmental, 
toxicological, medical as well as in defense applications (Alocilja and Radke 2003; 
Bousse 1996; Paddle 1996; Rodriguez-Mozaz et al. 2004). Such a rapid development in 
the field of biosensors can be attributed to the fact that biosensors have immense potential 
to act as low – cost yet rapid and sensitive measuring tools. 
The classification of a biosensor is broadly based on the following: 
a) the recognition element, 
b) immobilization techniques, 
c) the principle of detection and  
d) applications 
 
Recognition Element 
A biosensor can be divided into three categories based on the recognition element, 
namely molecular sensors, cellular sensors and tissue based sensors. In molecular sensors, 
biomolecules such as enzymes, cell receptors, antibodies, nucleic acids etc act as the 
sensing elements whereas in cell or tissue based sensors microorganisms, mammalian 
cells or slices of tissue constitute the recognition unit.  
Enzymes, the biocatalysts, are the most common biological elements in 
biosensors. Enzymes catalyze numerous reactions when they come in contact with the 
substrate. The most common enzyme biosensor is the sensor for detecting glucose, where 
the glucose oxidase (GOX) enzyme oxidizes glucose to gluconic acid and hydrogen 
peroxide (Eq. 2.1). The decrease in concentration of oxygen is measured using an oxygen 
electrode. 
 5 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1  Schematic showing the components of biosensor, modified from Eggins 1996. 
The signal arising out of the interaction between the biological detector and analyte is 
converted into electrical signal by the transducer. The signal is then processed by signal 
processor. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Signal Measuring 
DeviceAnalyte
Signal
Transducer
Biological
Detector
 6 
 
glucose + O2             gluconic acid + H2O2    2.1 
 
Another common example of an enzyme based biosensor is when urease is used to 
measure urea by breaking down urea to ammonia and carbon dioxide. 
The above two scenarios are examples of enzyme based biosensors where purified 
enzymes have been immobilized on the surface of a transducer. However, instead of 
using purified enzymes, in many cases cells or slices of tissue are used as the sources of 
enzymes for catalyzing reactions. The most well known tissue based biosensor is the 
“bananatrode”. The fact that banana tissue contains polyphenolases which in turn can 
oxide molecules containing catechol groups was used to develop a biosensor for 
dopamine (Sidewell and Rechnitz 1985). Another example involves the breakdown of 
arginine by bovine liver to urea and orthinine (Rechnitz 1978). Microorganism based 
biosensors involving bacteria, yeast or fungi find applications such as in waste water 
treatments, brewing industries and detection of pesticides (Lei et al. 2005; Rodriguez-
Mozaz et al. 2004). 
Other known biological components of biosensors include antibodies, nucleic 
acids and receptors. Antibody based biosensors involve the highly specific interactions 
between the antibodies and the antigenic regions of the substrates. Interactions between 
the antibodies and antigens have been utilized in many optical and piezoelectric 
biosensors for detection of cocaine, trinitrotoluene, toxins like Clostridium botulinum and 
ricin as well as contaminants of food like mycotoxins (Devine et al. 1995; Narang et al. 
1997; Ogert et al. 1992; Suleiman and Guilbault 1994; Thompson and Moragos 1996; 
Whelan et al. 1993). Hybridization of known DNA probes with the complimentary 
strands in the test sample acts as the backbone of the nucleic acid based biosensors. 
Specificity of nucleic acid based sensors are higher than antibody based sensors as 
antibodies at times can react with antigens other than the analyte of interest (Pancrazio et 
al. 1999). However, extensive sample preparation, hybridization and amplification limit 
the application of the nucleic acid based sensors. 
 
 
GOX 
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Immobilization Techniques 
Biosensors can also be classified on the basis of the mode of biomolecule immobilization 
on the transducer surface. Immobilization of biomolecules plays a critical role in 
biosensor stability and performance. Figure 2.2 represents a schematic of some of the 
common techniques for biomolecule immobilization. The methods include adsorption of 
the biomolecule on the surface, covalent binding between the biological component and 
the transducer surface, cross-linking between molecules, entrapment of the biological 
component within a gel matrix or polymer and microencapsulation of the biological 
element within membranes (Collings and Caruso 1997; Eggins 1996). The adsorption of 
biomolecules on the sensor surface can either be based on weak forces like van der Waals 
forces, hydrogen bonding or electrostatic interactions (physisorption) or much stronger 
chemical bonds in the case of chemisorption. Even though physisorption involves the 
simplest approach of biomolecule incorporation, the strong dependence of the binding 
forces on pH, temperature and ionic strength, however reduces biosensor stability (Ahuja 
et al. 2007). Incorporation of crosslinking agents such as glutaraldehyde, hexamethyl 
diisocyanate and 1,5–dinitro-2,4 difluorobenzene between the biomolecule and 
transducer can eliminate some of the problems associated with the physisorption method. 
For example co-immobilization of acetylcholine (AChE) with choline oxidase (ChO) on 
a Pt surface in the presence of glutaraldehyde resulted in increased enzyme attachment on 
the transducer surface (Amine et al. 2006). Glutaraldehyde was once again the crosslinker 
during the immobilization of AChE in a nylon net on a gold electrode (Gulla et al. 2002). 
However, denaturation of the enzyme due to crosslinking, diffusion limitations as well as 
the poor stability of the biosensors due to exposure of the enzyme to the bulk solution are 
some of the limitations of this immobilization technique (Amine et al. 2006). 
Microencapsulation, one of the oldest immobilization techniques, involves the use of a 
membrane for trapping the biomaterial (Eggins 1996). For example, clinically important 
biosensors were constructed by physically trapping various oxidoreductase enzymes in 
poly (2-hydroxylethyl methacrylate) hydrogels (Brahim et al. 2002). Layer by layer 
deposition of polyallylamine hydrochloride /polystyrene sulphonate on GOX 
microparticles resulted in enhanced loading of the enzyme (Trau and Renneberg 2003). 
The matrix entrapment of the biomolecule is also used where the biomolecule is mixed  
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Figure 2.2  Schematic showing the different techniques of biomolecule immobilization 
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with the monomer and polymerized to form a gel entrapping the biomolecule (Eggins 
1996). Entrapment of GOX during the growth of an osmium complex modified 
polypyrrole has been demonstrated (Reiter et al. 2001). Careful tailoring of covalent 
bonds between the sensor surface and the biomolecule by utilizing the functional groups 
of the biomolecule which are not essential for its activity is another method of 
biomolecule immobilization. The advantages of this method include low mass transfer 
resistance and reduced leaching of the biomolecule. Some examples of covalent 
immobilization of biomolecules include the binding of GOX to poly(o-amino benzoic 
acid) for glucose sensing, pyruvate oxidase binding to nanoparticle containing 
poly(terthiophene carboxylic acid) for phosphate ion detection and tyrosinase binding to 
an electrochemically prepared copolymer poly(N-3-aminopropyl pyrrole-co-pyrrole) film 
for detection of phenol (Rahman et al. 2006; Rajesh et al. 2004; Ramanathan et al. 2000). 
Recent research efforts have been directed towards entrapping biomolecules within 
electrochemically synthesized polymers. Presence of conjugated π electron backbones in 
the electroactive polymers has induced in them electrochemical properties such as high 
conductivity and electron affinity. Some of these common conducting polymers are 
polyacetylene, polyaniline, polypyrrole and polythiopene (Ahuja et al. 2007). Studies 
have demonstrated improved stabilization of enzymes such as GOX, urease and 
glutamate dehydrogenase when incorporated into conducting polymers (Gambhir et al. 
2001; Reiter et al. 2001).  
 
Principle of Detection 
Biosensors can also be classified based on the type of transducer.The most common type 
of transducer is the electrochemical transducer. The indifference of the electrochemical 
transducers to the turbidity or color of the sample solution, simple equipment set up and 
relatively easy calibration in aqueous solution have enabled these sensors, based on 
potentiometry, amperometry or conductivity measurements, to become popular in the 
fields of analytical and clinical chemistry. The most common potentiometric transducer is 
the ion selective electrode (ISE), which measures cell potential at zero current. ISEs are 
mostly used as enzyme biosensors, whereby changes in the concentration of ions due to 
the enzymatic catalysis of the reaction lead to a change in potential (Racek 1995). 
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Optical transducers measure a change in photometric properties. Interaction 
between a receptor and an analyte can lead to the formation of a product with different 
photometric properties. Biosensors based on optical transducers can then detect the 
analytes by utilizing common techniques like ultraviolet-visible as well as fluorescence 
spectroscopy, bioluminescence, chemiluminescence and internal reflection spectroscopy. 
The following is an example of a biosensor involved in the detection of creatine kinase, 
by utilizing bioluminescence by luciferin. Creatine kinase converts creatine phosphate to 
creatine along with the production of ATP. This ATP can then act as a cofactor in 
oxidizing luciferin to oxyluciferin, thereby emitting luminescence (Eggins 1996). 
 
AMP + creatine phosphate                                        ATP + Creatine 2.2 
 
ATP + luciferin + O2  AMP + pyrophosphate + CO2 + 
oxyluciferin  + h         2.3 
 
Biosensors based on the principle of surface plasmon resonance (SPR) have been 
increasingly used in food industries for detecting food borne pathogens such as Listeria 
monocytogenes and E. coli O157:H7 (Leonard et al. 2005; Waswa et al. 2007). SPR 
biosensors are also used for detecting various pesticides, proteins, veterinary drug 
residues in milk products such as chloramphenicol, penicillin and streptomycin (Baxter et 
al. 2001; Gaudin et al. 2001; Gaudin and P.Maris 2001; Gustavsson et al. 2004; Mauriz et 
al. 2007). SPR biosensors are optical biosensors which measure the change in refractive 
indices on the sensor surfaces due to the interactions between the sensing elements and 
the analytes. SPR biosensors are advantageous over spectroscopy based biosensors due to 
the fact that they employ a label free mode of operation for detecting analytes (Eggins 
1996). 
Piezoelectric biosensors find their applications in pesticides as well as in health 
care (Abad et al. 1998; Suleiman and Guilbault 1994; Zhou et al. 2002). A piezoelectric 
biosensor consists of a piezo crystal with a characteristic resonant frequency. The 
resonant frequency depends on the mass of the crystal as well as that of the coating. 
Adsorption and desorption of analytes from the crystal surface leads to a change in the 
Creatine kinase 
luciferase 
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resonant frequency ( f ). The change in frequency can then be related to the change in 
mass according to equation 2.4.  
                     AmKff /2       2.4 
where A is the sensor area, f is frequency and K is equilibrium constant (Eggins 1996). 
Quartz crystal microbalance (QCM) is the most commonly known piezoelectric biosensor. 
The QCM based biosensors have been used in many applications ranging from detection 
of HIV – 1 tat protein to Salmonella sp. in milk samples (Park et al. 2000; Tombelli et al. 
2005). 
Biochemical reactions generate or adsorb heat. Thermal based biosensors measure 
the change in heat and relate it to the extent of the reaction. This technique involves the 
use of highly sensitive thermometers having the ability to track changes in temperature as 
low as 0.001 
0
C. Thermal biosensors have been used mostly for detecting pesticides 
(YiHua et al. 2005a; YiHua et al. 2005b). 
 
Applications 
Biosensors are increasingly used in the food and agricultural industry, environmental, 
toxicological as well as in defense applications and most importantly in medical 
applications.  
 Conventional methods for analyzing the body fluids involving chemical analysis 
of samples of blood, urine, etc require several days. This becomes critical for patients in 
intensive care or in emergency situations. This problem resulted in the patronization of 
sensors in the field of health care. Biosensors provide fast on the spot analyses of body 
fluids. Biosensors can analyze body fluids to determine the levels of glucose, sodium, 
potassium, calcium, creatine kinase, ammonia, etc in a very short time. The first 
biosensor that was successful commercially was the glucose sensor launched by Exatech 
in 1987.  
 The detection of contaminants in food, monitoring the quality of food and product 
freshness are some of the areas where biosensors can be potentially utilized in the food 
industry. Another requirement in the food industry is the identification of different 
components of food like vitamins, essential amino acids, flavoring agents, preservatives, 
allergens etc on the food labels. Researchers have also demonstrated the ability of a 
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biosensor array to detect food allergens as well as common proteins and amino acids 
(Sarkar and Turner 2004; Shriver-Lake et al. 2004). Researchers have shown that 
biosensors have the ability to detect various drug residues in milk products such as 
chloramphenicol, penicillin and streptomycin (Baxter et al. 2001; Gaudin et al. 2001; 
Gaudin and P.Maris 2001; Gustavsson et al. 2004). Opportunities exist for applications of 
biosensors in the beer industries to control and improve their products. Researchers have 
shown that enzyme based biosensors are capable of detecting diacetyl in beer (Vann and 
Sheppard 2005). The fact that biosensors are inexpensive yet highly selective is 
increasing their chances of success in modern food production technology. 
 With the high demands for treatment of industrial and urban wastewater effluent, 
recent years have seen a tremendous boost in the development of biosensors for water 
treatment. Increased use of pesticides has resulted in their widespread presence in water 
and soil. Recent efforts have been directed in the detection of organophosphorous and 
carbamate pesticides by using biosensors (Abad et al. 1998). Conventional techniques 
used for detecting heavy metals like Cu
2+
, Cd
2+
, Zn
2+
, Hg
2+
, etc. are facing tough 
competition from biosensors. In general, while cell based biosensors have been used for 
determining the toxicity of heavy metals (Campanella et al. 1996; Liu et al. 2007), 
enzyme based biosensors are generally used for monitoring levels of metals. 
 Over recent years, the defense and security industries have witnessed a rapid 
growth in the development of biosensors. The terrorist attacks and the wave of anthrax 
letters have revealed the endangered conditions of the civil populations, thereby 
providing the required momentum for research involving biosensors. Detection of 
hazardous materials or germs, chemical warfares, illicit drugs, explosives etc are some of 
the avenues where biosensors can find potential applications. Researchers have already 
demonstrated the ability of biosensors to detect explosives and nerve agents (Lei et al. 
2005; Whelan et al. 1993). 
 
2.2  Tissue and Cell-Based Biosensors 
Even though research on cells has been carried out for a very long time, the concept of 
using cells as the recognition element to detect different analytes is comparatively new 
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(Bousse 1996). The potential applications of whole cell based biosensors are in the field 
of drug discovery, clinical diagnostics and for monitoring toxins, chemicals, heavy metals, 
pesticides or herbicides (Bousse 1996; Campanella et al. 1996; Liu et al. 2007; Pancrazio 
et al. 1998; Pancrazio et al. 1999; Ziegler 2000). There are several advantages of using 
cell based biosensors over the commonly used enzyme or antibody based biosensors. 
Purification and isolation of enzymes are difficult, and many enzymes lose their activity 
during these stages. These stages can be readily omitted if cellular and tissue biosensors 
are used. In addition, cells are more tolerant over a range of temperature and pH  than the 
purified enzymes or other proteins (Eggins 1996; Racek 1995). Moreover, the enzymes 
being within the cell, their natural environment, are more stable as they are less 
susceptible to denaturation. As a result, the lifetime of cell based biosensors is much 
longer than the enzyme based sensors. For example, while the glutaminase based 
biosensor for detecting glutamine is useable only for one day, the bacterial cell Sarcina 
flava based sensor can be used over a period of twenty days, and the tissue based 
biosensor containing a slice of porcine kidney is stable for a month. Whole cells are the 
smallest self sustaining biological entities; thus, if cells can be used for the sensor, the 
sensors become inexpensive (Eggins 1996; Racek 1995). On the other hand, since the 
substrate now has to diffuse through the cell membranes before coming in contact with 
the enzyme, the response time of these sensors can be greater. Secondly, since cells/tissue 
host multiple enzymes within them, the selectivity associated with purified enzyme based 
sensors is reduced. For example, banana tissue, containing polyphenolases, can be used to 
determine dopamine, a catecholamine as well as catechol itself and flavanols (Eggins 
1996; Sidewell and Rechnitz 1985). 
These sensors can be further categorized based on cell type depending on whether 
microorganisms, mammalian cells or animal or plant tissue have been immobilized 
(Racek 1995; Ziegler 2000). Cell based biosensors can also be categorized on the basis of 
their measurement principle (Ziegler 2000). Some examples where the whole cell based 
sensor technology has been used include: (i) measurement of the metabolic products / 
energy metabolism and (ii) measurement of the mechanical contact between cells and 
between cell and substrates (Pancrazio et al. 1999; Ziegler 2000). Metabolic activity in 
cells can be measured by the rate of acidification of the extracellular environment of the 
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cells (Owicki and Parce 1992) or by the change in the oxygen, glucose or lactose content 
(Ziegler 2000). For measuring the cell-cell contact, the cells are either cultured on an 
array of planar electrodes or on the top of a water porous filter membrane.  
 
2.2.1 Tissue Based biosensors 
Biosensors based on tissue slices are easy to prepare. A slice of tissue can be cut with a 
razor blade and directly placed on the transducer surface or can be immobilized within a 
semipermeable membrane such as a nylon mesh (Racek 1995). Because the integrity of 
the tissue is high, chances of single cell detaching from the surfaces are low. Moreover, 
slices of tissue from plants like spinach leaf, ground beet root or banana pulp can be 
mixed with graphite powder and mineral oil to form a carbon electrode paste (Racek 
1995).  Similarly, tissue slices from animals have also been used as the recognition unit. 
For example, tissue from white pig liver has been used for detecting uric acid (Wu et al. 
2005b). The presence of urate oxidase in the tissue has been utilized to oxidize uric acid 
to produce hydrogen peroxide. H2O2 thus produced, reacts with luminol in the presence 
of potassium hexacyanoferrate (III) generating chemiluminescence signal (Wu et al. 
2005b).  Similarly, tissue slices from heart and kidney from pork have been used for 
detecting pyruvic and lactic acid respectively (Wu et al. 2006; Wu et al. 2005a). Tissue 
based biosensor can be stored for long time without affecting its applicability. For 
example, ascorbate oxidase activity in a tissue slice from yellow squash was retained for 
one year (Macholan and Chmelikova 1986). Table 2.1 lists some tissue based biosensors. 
 
2.2.2  Microbial Cell-Based Biosensors 
Microorganisms such as yeast, bacteria and algae, play critical roles in biotechnology 
processes such as fermentation, waste water treatment etc. Over the years, the 
applications of microbial cells as biosensors have ranged from detection of chemicals and 
pesticides to monitoring water quality. Sensors incorporating cells from bacteria and 
yeast coupled with oxygen electrodes have been used to detect many chemicals including 
formaldehyde (Korpan et al. 1993) and cholanic acid (Campanella et al. 1996). The 
alteration in the reduction of the iron complex ([Fe(CN)6]
3-/4-
) due to the change in the 
photosynthetic activity of cyanobacteria in the presence of herbicides has been utilized to  
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Table 2.1  Tissue Based Biosensors. (Modified from Eggins 1996, Racek 1995) 
 
Substrate Tissue Device/Probe 
Glutamate Yellow squash CO2 
Dopamine Banana pulp O2 
Tyrosine Sugar beet O2 
Cysteine  Cucumber leaf NH3 
Ascorbic acid Yellow squash O2 
Catecholamines Spinach leaf O2 
Asparagine Petal of magnolia NH3 
Glutamine Porcine kidney NH3 
Hydrogen peroxide Bovine liver O2 
Oxalate Banana skin H2O2 
AMP Rabbit Muscle NH3 
Guanine Rabbit Liver NH3 
Glutamine 
Porcine kidney 
mitochondria 
NH3 
Adiuretine Toad Bladder Na
+
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detect the presence of herbicides (Rawson et al. 1989). Another approach using microbial 
cells is to immobilize genetically engineered cells on a sensor surface. Sensors containing 
bacterial cells with bioluminescent reporter genes have been utilized in the detection of 
benzene, toluene and mercury (Applegate et al. 1998; Burlage et al. 1994; Selifonova et 
al. 1993). Another example is the utilization of the genetically engineered E. coli, 
expressing organophosphate hydrolase enzyme, to detect insecticides or nerve agents 
such as sarin gas (Campanella et al. 1996; Pancrazio et al. 1999). The presence of toxic 
compounds has been determined by using light producing genes as the reporter genes. In 
these toxicity assays, genetically engineered bacterial cells, expressing lux gene, are used. 
Decrease in the production of the light can then be related to the presence of the toxic 
elements in the sample (Hansen and Sorensen 2001). Table 2.2 lists some common 
microorganism based biosensors.   
 Freeze drying of bacterial and yeast cells have been utilized to store the microbial 
cells over a substantial period of time. Moreover, these sensors can also be stored at + 4 
0
C by immersing the electrode tip in the working buffer containing required nutrients 
(Racek 1995).  
 
2.2.3  Mammalian Cells-Based Biosensors 
Recent years have witnessed tremendous interests in studies related to the structure, 
function and characteristic of mammalian cells.  The fact that these cells house many 
proteins, enzymes and receptors enables them to respond to many biological analytes. As 
a result, the applications of the mammalian cell based sensors range from screening drugs 
to determining toxins and monitoring the environment. The increased applications of cell 
based biosensors are also expected to reduce the use of live animals for drug testing 
purposes.  
 Rapid developments in organic chemistry and genomics have led to the discovery 
of molecules having the ability to act as drugs. Sensitive screening tests of these potential 
drugs are necessary to identify the most promising candidates. Cell-based biosensors 
have been increasingly used for this screening purpose. For example evaluation of the 
chemosensitivity of tumor cells has been used to predict the effect of anticancer drugs on  
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Table 2.2  Microbial Cell Based Biosensors (Modified from Eggins 1996 and Racek 
1995) 
 
Substrate Microorganism Device/Probe 
Glucose Pseudomonas 
fluorescence 
O2 
Acetic Acid Trichosporon brassicae O2 
Ethanol Trichosporon brassicae O2 
Glutamic acid Escherichia coli CO2 
BOD Trichosporon cutaneum O2 
Ammonia Nitrifying bacteria O2 
Ascorbic acid Enterobacter 
agglomerans 
O2 
Asparagine Serratia marcescens NH3 
Aspartame Bacillus subtilis O2 
Arginine Streptococcus lactis NH3 
Cholesterol Nocardia erythrocytes O2 
Cysteine Proteus morgani H2S 
Lactate Escherichia coli O2 
Methane Methylomonas 
flagellate 
O2 
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patients (Metzger et al. 2001; Torisawa et al. 2003; Torisawa et al. 2004; Torisawa et al. 
2005). For this purpose, the effect anticancer drugs such as 5-fluorouracil, adriamycin,  
ocetaxel, cisplatin and paclitaxel on different human cancer cell lines such as MCF-7, 
BT474, PC12, A549, HL-60 and K562 were determined (Metzger et al. 2001; Torisawa 
et al. 2003; Torisawa et al. 2004; Torisawa et al. 2005). 
Heavy metals being toxic pose great threat to human health even when present in 
trace amounts. It is not the total concentration of these metals, but rather the bioavailable 
concentration that correlates with toxicity. This initiated the development of mammalian 
cell-based sensors for toxicity determination. Researchers have shown that cardiac cell 
based biosensors can detect different heavy metal ions such 
as Hg
2+
, Pb
2+
, Cd
2+
, Zn
2+
, Cu
2+
 and Fe
3+
 at concentrations of 10 M within 15 min (Liu et 
al. 2007). Exposure of the cardiac cells, cultured on light addressable potentiometric 
sensor, to these heavy metals resulted in change in frequency, duration and amplitude of 
sensor signals. Another approach for monitoring environmental conditions has been in 
the development of the olfactory cell based sensor. Recent research has demonstrated the 
ability of an olfactory cell based biosensor to act as potential bioelectronic nose (Liu et al. 
2006). 
Another type of mammalian cell-based sensor was developed to measure 
metabolic rate. The rate of metabolism can be obtained from the rate of acidification of 
the extracellular environment of the cell or from the change in concentration of oxygen, 
glucose etc (Owicki and Parce 1992; Ziegler 2000). Research has demonstrated that 
exposure of primary neurons to  - aminobutyric acid, an inhibitory neurotransmitter, and 
kainic acid, an excitatory neurotransmitter, led to an increase in cell metabolism and 
eventually to the increased rate of acidification of the extracellular environment 
(Pancrazio et al. 1999). 
 Another approach of mammalian cell-based biosensor relies on the mechanical 
contact between the cells. For this purpose, the cells are either cultivated directly on the 
top of electrodes or on top of water porous filter membranes. Impedance, measured as a 
function of time and changed environment, can be related to the change in the cell 
adhesion, spreading and motility (Giaever and Keese 1986, 1991, 1993; Mitra et al. 1991). 
The fact that intact living cells are good insulators at low frequencies has been utilized in 
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the development of sensors based on electric cell-substrate impedance sensing (ECIS). In 
the absence of cells on the electrode surface, there is but little impedance. As the cells 
grow and migrate to form confluent monolayer across the electrode surface, effective 
impedance increases. This technique has been utilized in detecting motion of cells at 
nanometer levels (Giaever and Keese 1991, 1993; Noiri et al. 1997). Impedance 
measurements have also been used to detect the effect of different inflammatory agents 
on the permeability of cell monolayers (Abdelghani et al. 2002; Hillebrandt et al. 2001).  
Impedance measurements of cell-cell contact has also been applied to investigate 
fundamental morphological science of cells such as studying healing of wounds induced 
in endothelial cell layers, blood-brain barrier properties or apoptosis (Arndt et al. 2004; 
Ziegler 2000). Table 2.3 lists some common mammalian cell based biosensors. 
 
2.3 Ion Selective Electrodes 
The present study utilizes mammalian cell permeability dysfunction to detect the 
presence of small quantities of permeability modifying agents. For the purpose, cells 
were seeded across the asymmetric cellulose triacetate (CTA) membrane of an ion 
selective electrode (ISE). Since ISEs play an integral part in the present study, 
background information on ISEs is provided in this section. 
Ion selective electrodes are electrochemical sensors which can determine the 
activity of specific ions in a sample, as a function of electromotive force (emf). Typically 
the primary components of a membrane based ISE are: (A) the indicator electrode or 
working electrode and (B) the reference electrode (Bakker et al. 1997). Figure 2.3 shows 
a schematic of an ISE. The indicator electrode consists of an inner reference electrode 
(Ag/AgCl), the inner filling solution and an ion selective membrane. The indicator 
electrode generates a potential corresponding to the activity of the ion of interest in the 
sample solution. The reference electrode maintains a constant potential against which the 
potential of the indicator electrode is measured (Morf 1981). The ion selective membrane 
acts as the barrier between the sample solution and the inner filling solution. In polymer 
membrane ISEs, the membrane consists of i) a plasticized polymeric phase, most 
commonly with poly (vinyl chloride) and cellulose triacetate as the polymer matrix, ii) an  
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Table 2.3 Mammalian Cell -Based Biosensors 
 
Substrate Cell type 
Hydrogen Peroxide Human erythrocytes 
Glutamine Pork kidney cells 
Anti tumor drugs Mouse leukemia cells 
Anti tumor drugs Human cancer cells 
Heavy metal ions Mouse cardiac cells 
Histamine 
Human umbilical veins 
endothelial cells 
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Figure 2.3  Schematic diagram of a membrane-based ISE. (Modified from Bakker et al. 
1997) 
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ionophore that provides selectivity to the membrane by binding specifically to the ion of 
interest, iii) a lipophilic salt that helps in maintaining the elctroneutrality within the 
membrane and iv) plasticizer that helps in dissolving of the ionophore within the 
membrane. Table 2.4 shows the typical composition of the membrane of an ion selective 
electrode.  
With ISEs, the changes in electromotive forces (emf) are measured, as a function 
of the activity of the ion of interest, under zero current conditions.   The response of the 
ISE can be described by the phase boundary model. The potential developed at the 
interface of the aqueous and the organic phase (the polymeric membranes are assumed to 
behave as the organic liquid) is measured by using the thermodynamic equilibria and 
electroneutrality conditions within each phase. This model assumes that the ion transport 
processes are considerably fast between the phases (Bakker et al. 1999). The other 
theories which describe the response mechanism of ISE are the kinetic or ion transport 
model and the membrane surface or space charge model (Morf 1981). However, the ion 
transport model, which considers that the selectivities are related to the ionic mobilities, 
reduces to the phase boundary model when the assumption of equal mobilities is made 
(Bakker et al. 1999). The space charge model assumes that the membrane surface 
processes are only relevant for the generated potential (Bakker et al. 1999). Since, this 
model also assumes the existence of equilibrium at the membrane surface, the obtained 
predictions about emf responses from this model are the same as the given by the phase 
boundary model (Bakker et al. 1999). Even though the latter two models explain the 
response mechanism in more detail, they also incorporate more assumptions and 
parameters (Bakker et al. 1999). It has been documented that the simpler phase boundary 
potential model has the ability to explain the experimental results satisfactorily (Bakker et 
al. 1997). 
In the phase boundary potential model, the relationship between the phase 
boundary potential, E, and the activities of the ions in both phases is given by: 
 E = E
0
 + 
)(
)(
ln 1
orga
aqak
zF
RT
m
m        2.5 
where, E
0
 incorporates the constant potential contributions. am (aq) and am (org) are the 
activities of the ion with z charge in the aqueous and organic phase. The free energy for  
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Table 2.4  Typical Composition of the Carrier Based Membrane of Ion Selective 
Electrodes 
 
Component  Composition 
Ionophore 1 wt% 
Plasticizer 65 wt% 
Polymer 33 wt% 
Lipophilic Additive 50 mol% (with respect to ionophore) 
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transfer of ion from the aqueous to the organic phase is incorporated into the constant 
term, k1. R, T and F are the gas constant, the absolute temperature and Faraday constant 
respectively. Assuming that the membrane phase composition remains constant as the 
sample composition is varied and there are no interferences from the other sample ions, 
the above equation reduces to the Nernst equation: 
 E = E
0
 + )(ln aqa
zF
RT
m        2.6 
For a monovalent ion at 25 
0
C, the above equation reduces to:  
E = E
0
 + )(log2.59 aqam        2.7 
Calibration curves are constructed by plotting the potential against the logarithm of the 
ionic activities. A typical calibration curve is shown in Figure 2.4. In the case of an 
asymmetric cellulose triacetate (CTA) potassium selective electrode, the slope of the 
calibration curve has been observed to be around 52  3 mV/decade (Brooks et al. 1996). 
According to IUPAC recommendation, detection limits of ISEs can be obtained in two 
different ways (Buck and Lindner 1994). Minimum detectable concentration is the 
concentration corresponding to the potential which deviates from the average potential of 
the electrode in the linear region of the plot by a multiple of standard error. The second 
method of obtaining the detection limit involves the extrapolation of the two linear 
regions of the curve. The concentration or activity corresponding to the intersection of the 
two extrapolations constitutes the detection limit of the electrode. The latter method is 
illustrated in Figure 2.4. 
Earlier studies have shown that incorporation of a confluent monolayer of human 
umbilical vein endothelial cells (HUVECs) onto the asymmetric CTA membrane resulted 
in inhibited response from the biosensor (May et al. 2005; May et al. 2004a) due to 
inhibition of potassium ion transfer by the cell monolayer. When the permeability across 
HUVECs is altered in the presence of histamine or VEGF, potassium ions can reach the 
membrane surface thereby leading to an increased sensor response (May et al. 2005; May 
et al. 2004b). The response thus obtained can be related to the concentration of these 
permeability modifying agents. In the present study, the mammalian cells used as the 
sensing device included HUVECs and porcine epithelial cells (LLC-PK1), and cell 
permeability dysfunction has been utilized to detect physiological toxins. 
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Figure 2.4  Typical calibration plot of an ISE. Modified from (Lazo et al. 2006) 
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Chapter 3 : Materials and Methods 
 
Cell culture, membrane fabrication and evaluation of the electrode response are some of 
the techniques used throughout this study. This chapter describes the methods employed 
as well as the reagents required for these techniques. However, specific experimental 
methods and corresponding materials for particular studies have been described in 
respective chapters. 
 
3.1  Cell Culture 
Human umbilical vein endothelial cells (HUVECs) and porcine epithelial cell - line LLC-
PK1 were cultured during the course of the research. Both cell types were cultured inside 
a sterile laminar flow hood and incubated in a humidified incubator maintained at 37 
0
C 
and 5% CO2. 
 
3.1.1  Reagents 
HUVECs obtained from Cambrex Bioscience (East Rutherford, NJ) were cultured in 
EGM-2 media, supplemented with fetal bovine serum, hydrocortisone, insulin like 
growth factor, basic fibroblast growth factor, vascular endothelial growth factor, human 
epidermal growth factor, ascorbic acid, human fibroblast growth factor, gentamicine 
sulphate, amphotericin-B and heparin, also obtained from Cambrex Bioscience. 
Trypsin/EDTA, trypsin neutralizing solution (TNS) and HEPES buffered saline solution 
(HBSS) were also from Cambrex Bioscience. 
 LLC-PK1 cells obtained from ATCC (Manassas, VA) was cultured in Medium 
199 (M 199) from Sigma Aldrich (Milwaukee, WI) supplemented with 3% fetal bovine 
serum (FBS). FBS and trypsin/EDTA were obtained from ATCC. 
 
3.1.2  Culturing HUVECs 
Upon arrival from Cambrex Bioscience, cells were stored in liquid nitrogen for future use. 
Before breaking cells out of freezing, HUVEC media was warmed for 45 min by placing 
it a water bath maintained at 37 
0
C. Ten milliliters of media was then aliquoted into a 75 
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cm
2
 cell culture flask. The vials containing the frozen cells were then taken out of the 
liquid nitrogen tank, the caps of the vials turned to release pressure and the cells thawed 
by holding the vial inside the water bath maintained at 37 
0
C until the last piece of ice 
started to melt. The vials were then wiped with 10% bleach and sprayed with 70% 
ethanol before placing them inside the laminar flow hood. The cells were transferred to 
the cell flask using a sterile transferring pipette. The cell flask was then placed inside the 
incubator. Following the breaking of cells out of freezing, the cell media was changed 
every 24 h until the cells became confluent. 
Once HUVECs were confluent, the media was aspirated and the cells were rinsed 
with 9 mL of HBSS. The cells were then incubated with 6 mL of trypsin/EDTA for 3 min. 
After the cells had detached from the cell culture flask, 12 mL of trypsin neutralizing 
solution was added. The cells were transferred to sterile centrifuge tubes and centrifuged 
for 5 min. Following centrifugation, the supernatant was removed, and the cells were 
resuspended in HUVEC media. The cells in each centrifuge tube were diluted in 10 mL 
HUVEC media and transferred to a different cell culture flask for further culturing. 
To ensure ample cells for future use, some cells were frozen and kept inside a 
liquid nitrogen flask. For the purpose of freezing the cells, the confluent cells were 
detached from the culture flask similarly as described above. The cells were centrifuged 
and the supernatant decanted, and the cells were resuspended. A volume of 2 mL of 
freezing media, consisting of 10% FBS, 10% DMSO and 80% HUVEC media, was then 
used to dilute the cells in each tube. The diluted solution was then transferred to the 
cryogenic vials. The vials containing the cells were initially kept in the freezer at -80 
0
C 
for 24 h before storing in the liquid nitrogen tank. 
 
3.1.3  Culturing LLC-PK1  
The same protocol as described in case of HUVEC was followed for breaking LLC-PK1 
out of freezing, except the media used was M199 supplemented with FBS. The media 
was changed twice a week, until the cells were confluent. 
Once the cells were confluent, the media was removed, and the cells were rinsed 
with 3 mL of trypsin/EDTA solution. The solution was removed, and the cells were then 
incubated at 37 
0
C for 10-15 min with 3 mL of freshly added trypsin/EDTA solution. 
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Once the cells had detached, fresh media was added to the cells and the cells were diluted. 
The diluted cells were then transferred to different culture flasks for further culturing. 
For the purpose of storing LLC-PK1 for future use, the cells were detached from 
the culture flask by incubating with trypsin /EDTA solution as described above. A 
volume of 7 mL of M199 media was then added to the culture flask and the cells were 
transferred to the centrifuge tubes. Following 5 min centrifugation, the supernatant was 
disposed off and the cells resuspended. A volume of 2mL freezing media consisting of 
95% culturing media and 5% DMSO was used to dilute the cells in each centrifuge tube. 
As described for HUVECs, the diluted LLC-PK1 were then transferred to cryogenic vials 
and stored at -80 
0
C for 24 h prior to storing in a liquid nitrogen tank. 
 
3.1.4  Counting Cells 
Cells were counted with the hemacytometer to determine the cell density. For the purpose 
of counting cells, the cells were detached from the cell culture flask and transferred to the 
centrifuge tubes as described above. A volume of 0.5 mL of cell solution was aliquoted 
from the centrifuge tubes. The cells were then diluted 10 fold with HBSS in case of 
HUVECs and with M 199 in case of LLC- PK1 and transferred to both chambers of a 
hemacytometer. The number of cells in the square at the center as well as at the four 
corners of the chamber was counted in each chamber. Figure 3.1 shows a schematic of 
hemacytometer and describes the process of counting cells. 
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Figure 3.1  Counting cells using hemacytometer 
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3.2  Fabrication of Asymmetric Cellulose Triacetate Membrane 
 
3.2.1  Reagents 
Cellulose triacetate (CTA) pellets, methylene chloride, chloroform, 1,1,2,2 
tetrachloromethane and all chloride salts were purchased from Aldrich (Milwaukee, WI). 
Valinomycin, the ionophore, was obtained from Calbiochem (San Diego, CA). The 
plasticizer o-nitrophenyl octyl ether (NPOE) and the lipophilic salt potassium 
tetrakis(chlorophenyl)borate (KTClPB) were from Fluka (Ronkonkoma, NY) whereas 
carbonyldiimidazole (CDI) and tris(hydroxymethyl)aminomethane (Tris) were from 
Sigma (St. Louis, MO). Deionized water obtained with a Milli-Q Water Purification 
System from Millipore (Bedford, MA) was used to prepare the aqueous solutions. The 
synthetic RGD peptide sequence (Gly-Arg-Gly-Asp-Ser (GRGDS)) was obtained from 
Bachem (King of Prussia, PA). 
 
3.2.2  Membrane Fabrication 
Earlier studies have demonstrated that hydrolysis of the asymmetric CTA membrane 
containing valinomycin as the ionophore facilitates further surface modification and 
biomolecule attachment (Brooks et al. 1996; Cha and M.E.Mayerhoff 1989; Cha et al. 
1995; Koncki et al. 1997; Sakong et al. 1996). The procedure for preparation of the RGD 
modified CTA membrane was adapted from May and coworkers (May et al. 2004b). 
 Figure 3.2 and Figure 3.3 demonstrate the schematic of the membrane preparation 
procedure as well as the chemistry involved in various steps of membrane preparation. 
Initially, the base layer solution, consisting of 74 mg of CTA dissolved in 1.1 mL 
methylene chloride, 0.4 mL cholorform and 0.4 mL tetrachloromethane, was cast in a 31 
m.m i.d. glass ring on a teflon plate. Following solvent evaporation, the bottom surface of 
the membrane was hydrolyzed by floating the membrane on 1.0 M sodium hydroxide 
solution for 4.5 hr. Next, the second layer consisting of the ionophore cocktail (35 mg 
CTA, 1 mg valinomycin, 0.42 mg KTClPB in 100 L NPOE, 0.8 mL chloroform and 0.8 
mL methylene chloride) was cast on the membrane, thereby making it sensitive to 
potassium ions. After solvent evaporation, when the two layers of membrane had fused to 
form a single asymmetric membrane, the surface of the membrane containing the  
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Figure 3.2  Fabrication of CTA membrane and seeding of cells 
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Figure 3.3  Chemistry involved in membrane preparation 
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hydroxyl groups was activated by incubating with 0.1 M CDI for 15 min. The surface 
activated membrane was then incubated overnight with 500 g/mL RGD peptide in 0.1 
M sodium carbonate solution (pH 9.5). This incubation facilitated the covalent coupling 
of the RGD peptide from the N-terminal amine to the membrane surface. Following 
incubation, the membrane was rinsed sequentially in 0.1 M sodium bicarbonate (pH 8.5), 
deionized water, acetate buffer (pH 4.0) and deionized water. The membrane was then 
exposed to germicidal UV overnight. The membranes were cut into 6 m.m i.d. disks and 
mounted into autoclaved ISE electrode bodies. Following conditioning in sterile 0.01 M 
KCl solution for 24 h, cells were seeded onto the membrane surface at a density of 1 x 
10
5
 cells/ml and incubated in a humidified incubator for 24 hr at 37 
0
C and 5% CO2  to 
ensure confluent monolayer formation.  
 
3.3  Evaluation of Electrode Response 
Following confluent cell monolayer formation, the control membranes were tested for 
inhibited ion response. The schematic of the cell based biosensor set up is shown 
demonstrated in Figure 3.4. The internal reference electrode was Ag/AgCl, and the 
internal filling solution consisted of 0.01 M KCl.  The external reference electrode 
consisted of a double junction Ag/AgCl electrode (Orion Model 90-02-00) with an Orion 
(90-02-02) internal filling solution and 0.1M Tris buffer (pH 7.5) in the outer 
compartment. Potentiometric responses were measured with a four channel high 
impedance amplifier interface (World Precision Instruments) connected to a Model 100 
Instrunet A/D converter. Instrunet Software on a Macintosh Power PC was used to 
analyze the data. To obtain the ISE response, a series of incrementally sized sterile KCl 
aliquots were added to the stirred sterile buffer solution. The measured potential (mV) 
was plotted against the logarithm of the concentration of the potassium ions in the bulk 
solution to generate the calibration plots. Overall responses obtained at 0.1 M KCl 
solution for the membrane with cells were compared with the responses obtained for the 
membrane alone; 0.1 M KCl was used because it is close to physiological ionic strength. 
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Figure 3.4  Schematic of cell- based biosensor set up 
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Chapter 4 : Biosensor Incorporating Cell Barrier Architectures for Detecting 
Staphylococcus aureus Alpha Toxin 
 
Based on studies published in: Ghosh, G., Bachas, L. G., Anderson, K. W. “Biosensor 
Incorporating Cell Barrier Architectures for Detecting Staphylococcus aureus Alpha 
Toxin” Analytical and Bioanalytical Chemistry, 2007, 387, 567-574 
 
4.1  Introduction 
Staphylococcus aureus is one of the most common bacterial pathogens involved in 
various infections such as septicemia, endocarditis, osteomyelitis and septic arthritis. It is 
the major cause of postoperative infections and also infections associated with prosthetic 
devices by forming biofilms on catheters (Marrie and Costeron 1984) and pacemakers 
(Marrie et al. 1982). As a matter of fact, the recent years have seen a dramatic increase in 
the number of patients infected with sepsis related to Staphylococcus aureus infections 
with high mortality rate (Sista et al. 2004). Isolation and cultivation of the pathogen and 
the use of antibodies against different antigens of S.aureus (Christensson et al. 1983; 
Julander et al. 1983) are the current methods used for diagnosis of different 
staphylococcal diseases. The major disadvantages associated with these methods are the 
lack of sensitivity and the time consumption. Recent efforts have focused on identifying 
different antigens that would provide better sensitivity and hence early diagnosis. 
Alpha toxin, a protein exotoxin produced by the majority (85-90%) of S. aureus 
strains (Mollby 1983), plays a critical factor in S.aureus induced pathogenicity.  In fact, 
the presence of alpha toxin has been implicated as a necessary criterion for biofilm 
formation by S.aureus (Caiazza and O'Toole 2003). Alpha toxin is also believed to be 
largely responsible in S. aureus induced keratitis (O'Callaghan et al. 1997).  This virulent 
factor of S.aureus exhibits haemolytic, cytotoxic, dermonecrotic as well as lethal effects 
on laboratory animals (Jonsson et al. 1985; Thelestam and Blomqvist 1988). The 
cytotoxicity of alpha toxin is attributed to its transmembrane pore forming ability leading 
to the leakage of ions and macromolecules, across the cell membrane, which eventually 
results in necrosis (Bhakdi S. 1991). Development of an enzyme immunoassay with 
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monoclonal antibodies (Soderquist et al. 1993a) as well as double antibody sandwich 
ELISA (Sarujballi and Fackrell 1984) for detection of staphylococcal alpha toxin has 
been reported. Depending on the methods employed, the assays require 6 h to overnight 
incubation for effective determination of alpha toxin (Sarujballi and Fackrell 1984; 
Soderquist et al. 1993a). 
This study describes the detection of Staphylococcal alpha toxin using a whole 
cell based biosensor. The biosensor consists of a confluent monolayer of human 
umbilical vein endothelial cells (HUVECs) seeded on to the surface of an asymmetric 
cellulose triacetate (CTA) membrane of an ion-selective electrode (ISE) (May et al. 
2004b). This sensor takes advantage of endothelial cell permeability dysfunction to detect 
the presence of small quantities of permeability modifying agents. Earlier studies with 
this electrode have shown that complete inhibition of ion transport across the membrane 
is observed when a confluent monolayer of HUVECs is formed (May et al. 2004b). This 
results in a reduced ISE response. Previous studies have shown that exposure of the 
biosensor to histamine and vascular endothelial growth factor (VEGF) resulted in an 
increased response from the biosensor, which can serve as an indirect measurement of the 
presence of these agents (May et al. 2005; May et al. 2004b).  
Previous studies have demonstrated that exposing purified alpha toxin to 
endothelial cell monolayers leads to the rounding up of cells (Menzies and Kourteva 
2000) and increase in permeability (Dorsch et al. 1999; Suttorp et al. 1985). Hence, it is 
hypothesized that this sensor can be used to measure the presence of alpha toxin. The aim 
of the present study was to determine the response of the sensor to the various 
concentration of alpha toxin. It was also our objective to determine the effect of exposure 
to alpha toxin on the integrity of cell-cell contacts, cell shape as well as on the 
interendothelial gaps formation. For the later purpose, the borders of HUVECs were 
stained with silver nitrate. Silver staining technique had been previously used to 
successfully determine the shape of cells (Killackey et al. 1986), neutrophil 
transmigration (Burns et al. 1997), and leukocyte attachment as well as to quantify the 
gap size and number (Hirata et al. 1995; McDonald 1994). 
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4.2  Experimental Section 
 
4.2.1  Reagents  
Purified Staphylococcal alpha toxin was purchased from List Biological Laboratories. 
(Campbell, CA). Glutaraldehyde, for fixing cells during silver staining, as well as silver 
nitrate was obtained from Sigma (St. Louis, MO). Cells were washed with Dulbecco’s 
phosphate buffered saline (D-PBS) from Invitrogen (Carlsbad, CA). Mowiol 4 -88, the 
mounting reagent, was from Calbiochem (San Diego, CA). HUVECs used during the 
experiments, were cultured as described in Chapter 3. Membrane materials and sensor 
preparation had also been described in Chapter 3. 
 
4.2.2  Evaluation of Electrode Response 
 Following confluent cell monolayer formation, the control membranes were tested for 
inhibited ion response. After the confirmation of the inhibited ion response due to the 
formation of the confluent monolayer, the cell-seeded membranes were exposed to 
varying concentrations (ranging from 0.1 ng/ml to 1000 ng/ml) of Staphylococcal alpha 
toxin solution (pH 7.2) in PBS for 20 min. The response of the sensor was measured after 
20 min. 
At a final concentration of 0.1M KCl, the electrode response was measured for 
the following conditions: (a) the membrane without cells and without alpha toxin to 
obtain the baseline response of the sensor (b) membranes without cells and with 1000 
ng/ml alpha toxin to test the effect of the maximum concentration of alpha toxin on the 
sensor alone (c) membranes with cells and without alpha toxin to confirm the inhibited 
response of the sensor due to the confluent monolayer of cells and (d) membranes with 
cells and with alpha toxin at concentrations ranging from 0.1 ng/ml to 1000 ng/ml. To 
optimize the exposure time, the cell based membranes were exposed to alpha toxin for 10, 
20, 30, 60 and 90 min. 
 
4.2.3  Data Analysis  
To account for slight variations between fabricated membranes, the final data are 
reported as the ratio of the response obtained at 0.1 M KCl for the ISEs with HUVECs 
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and alpha toxin to the response obtained for the same membrane without HUVECs and 
alpha toxin. Data are reported as mean  SEM of three replicates. Multiple pairwise 
comparisons were carried out using one-way ANOVA and the Student-Newman-Keuls 
test for post-hoc comparisons of the means with P<0.05. SigmaStat v3.1 software was 
used for this purpose. 
 
4.2.4  Silver Staining of HUVEC monolayers  
To examine the effect of alpha toxin on the morphology of HUVECs, the cell monolayers 
were fixed and borders were stained following the method adapted from Burns and 
coworkers (Burns et al. 1997). Briefly, HUVECs were seeded on glass chamber slides at 
a density of 1x10
5
 cells/ml and cultured till confluency were reached. The confluent cell 
monolayers were treated with alpha toxin at concentrations varying from 0.1 to 1000 
ng/ml for 20 min, the exposure time required by the sensor to detect the presence of the 
toxin. After the incubation period the toxin solutions were aspirated and the monolayers 
were fixed in 0.05% glutaraldehyde in PBS for 10 min at room temperature. This was 
followed by washing with D-PBS for three times. The cells were then exposed to the 
aqueous solution of 0.25% silver nitrate for 40 s. Following the incubation with the silver 
solution, the cells were washed again with D-PBS for three times. The silver stain was 
developed by exposing the cells to UV for 15 min. Cells were then mounted using 
Mowiol 4-88 and viewed under Zeiss IM 35 microscope. In each study, three 
independent images were photographed from randomly selected fields of view. The 
dimensions of endothelial cells, silver lines, number and size of silver deposits were 
measured using AxioVision 4 software. Gap size was determined by subtracting two 
times the thickness of the silver lines from diameter of the silver deposits (Baluk et al. 
1997). 
Average values of the dimensions of cells and number and size of silver deposits are 
presented as mean  SEM of three experiments. As mentioned earlier statistical analysis 
were carried out using one-way ANOVA and the Student-Newman-Keuls test for post-
hoc comparisons of the means with P<0.05. SigmaStat v3.1 software was used for this 
purpose. 
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4.3  Results and Discussion 
Earlier studies have demonstrated that the immobilization of RGD peptide on the ISE 
membrane surface does not give rise to a mass transfer resistance and affects the sensor 
response minimally (May et al. 2004b). It had also been shown that with the growth of 
cells, the overall ISE response decreases, eventually leading to an almost completely 
inhibited response upon formation of a complete confluent monolayer after 24 h (May et 
al. 2004b) After the inhibited ion response was obtained, experiments were conducted 
with cells and alpha toxin.  
 
4.3.1  Optimization of Exposure Time 
Initially, experiments were performed to optimize the exposure time by exposing cell - 
based ISE membranes to 1000 ng/ml alpha toxin solution for 10, 20, 30, 60 and 90 min. It 
became important to optimize the exposure time such that not only an increased overall 
response would be obtained but also no damage would be caused to the cells seeded on 
the membrane. Calibration plots for potassium were constructed using these ISEs. An 
increase in the sensor response was observed with increasing exposure time (Fig. 4.1). 
Microscopic studies revealed that prolonged exposure to alpha toxin, at this concentration, 
led to detachment of cells. These results are consistent with the other studies in literature 
demonstrating that direct application of 5 nM alpha toxin to cultured endothelial cell 
monolayers for 24 h caused detachment of cells followed by apoptosis (Menzies and 
Kourteva 2000). Moreover, it had been also shown that application of 5 -40 ng/ml alpha 
toxin in isolated rabbit lung for 40-120 min led to condensation of nuclei of the 
endothelial cells and eventually, detachment of cells from the basal lamina (Seeger et al. 
1990). Upon exposing the cultured HUVECs to 1000 ng/ml alpha toxin for varying 
length of time, it was observed that no damage was induced to the cells when HUVECs 
were exposed to alpha toxin for 20 min. In addition, a significant difference in sensor 
response was observed at this time when compared to the response with cells only. Hence 
forth, all experiments with the sensor were carried out by exposing it to alpha toxin 
solution for 20 mins. 
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Figure 4.1  Calibration plots corresponding to (A) control, (B) cells only, (C - G) ISE 
electrodes with confluent monolayer of HUVECs were exposed to 1000 ng/ml alpha 
toxin for (C) 10 min, (D) 20 min, (E) 30 min, (F) 60 min, and (G) 90 min.  
 
 
 
 
 
 
 
 
 
 
 
 
 
D 
F 
A 
B 
C 
G 
E 
 41 
4.3.2  Evaluation of the Response from the Biosensor 
Since the highest concentration of alpha toxin used in this study was 1000 ng/ml, control 
experiments were first performed without cells to confirm that alpha toxin does not affect 
the sensor response by itself. Figure 4.2 reveals that the response profile obtained from 
the sensor upon exposure to the toxin for 20 min matches closely with that of the control. 
When the overall response obtained at 0.1 M KCl for the membrane exposed to toxin for 
20 min was compared with that obtained for control, it was observed that 98% of the 
sensor response had been recovered indicating minimal protein adsorption on the sensor 
surface.  
The cell based membranes were then exposed to different concentrations of alpha 
toxin for 20 min and the response of the sensor to the presence of the toxin was measured. 
Figure 4.3 illustrates the overall response ratio with increasing alpha toxin concentration. 
The overall response ratio of the sensor increased from 0.07 to 0.20 on varying the alpha 
toxin concentration from 0.1 to 1000 ng/ml. TableCurve 2D v 5.01 was used to fit the 
experimental data to the following equation (R
2
 = 0.994):  
Response Ratio = 0.0417 + 0.0433 x [Alpha Toxin]
0.182 
  (Equation 2.1) 
The above equation was used to determine the detection limit of this biosensor for alpha 
toxin.  
 
4.3.3  Determination of Detection Limit 
Figure 4.4 shows a plot of the total response ratio vs. logarithm of alpha toxin 
concentration. This is a standard curve used for determining the detection limit of alpha 
toxin using IUPAC recommendations (Buck and Lindner 1994). The detection limit 
obtained from the intersection of extrapolated parts of two linear regions of the curve is 
approximately 0.05 ng/ml of alpha toxin. The detection limit was also determined by 
using equation 2.1.  Minimum detectable concentration of alpha toxin by the biosensor 
was considered to be the concentration at which the response deviates from the average 
response of the sensor in the linear region by three times the standard error. By 
substituting this response ratio value in equation 1, the detection limit of the sensor for 
alpha toxin was found to be approximately 0.1 ng/ml. 
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Figure 4.2  Calibration plot for the ISE membranes (A) without cells and without alpha 
toxin and (B) without cells and exposed to 1000 ng/ml alpha toxin for 20 min. This plot 
represents one experiment. The experiment was repeated two more times giving similar 
results 
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Figure 4.3  Plot of the ratio of ISE response obtained at 0.1 M KCl following exposure to 
alpha toxin concentration ranging from 0.1-1000 ng/ml to ISE response obtained at 0.1 
KCl for the membrane without cells and without alpha toxin. (Error bars represent SE 
N=3)  
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Figure 4.4  Detection limit was obtained from the point of intersection of the 
extrapolated parts of two linear regions as indicated  
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Considering the fact that the acute toxic concentration of alpha toxin in human is 
100-250 ng/ml of whole blood [Bhakdi 1989], it is proposed that the sensor can be used 
to detect alpha toxin in the serum of patients infected with staphylococcal diseases. 
 
4.3.4  Changes in Morphology of HUVECs 
Silver staining was used to investigate changes in HUVEC morphology due to exposure 
to alpha toxin and the results are summarized in Table 4.1. Without alpha toxin, it was 
observed that the confluent monolayer of HUVECs was stained consistently along the 
contours of the cell borders. The number of intercellular gaps was quantified from the 
number of silver deposits (dots) along the stained borders of the cells. In the absence of 
alpha toxin treatment, few dots (0.4  0.08/endothelial cell) were observed along the cell 
borders (Fig. 4.5A), even though numerous silver dots were seen on the cell surface. 
Other studies have also reported the presence of such silver granules on the surfaces of 
cells (Hirata et al. 1995; McDonald 1994). 
 With the stimulation of HUVEC monolayers with alpha toxin, a significant 
increase in the number of silver deposits were observed along the border of the cells (Fig. 
4.5 B and C). When increasing the alpha toxin concentration from 0.1 ng/ml (Fig. 4.5B) 
to 1000 ng/ml (Fig. 4.5C), the number of silver deposits increased from 0.8  0.18 to 4.4 
 0.31 per cell. The thickness of the silver stained border (silver line) between the cells 
was determined to be 0.58 0.05 m (N = 20). Silver dots consist of approximately 
circular depositions of silver, at the intercellular gaps, surrounded by the silver lines as 
shown in Figure 4.6.  The gap diameter was calculated by subtracting twice the silver line 
thickness (2 X 0.58 m) from the diameter of silver dots. Almost no significant 
difference was observed in the gap size, as reflected from the average gap diameter of 0.9 
 0.02 m and 0.92  0.08 m for cells exposed to 0.1 ng/ml and 1000 ng/ml alpha 
toxin respectively. Gap area, expressed as percentage of total area, increased from 0.04  
0.007 for control to 0.41  0.02 m
2
 for cells treated with 1000 ng/ml alpha toxin. 
Exposing the confluent monolayer to alpha toxin had a little effect on cell shape as shown 
in Table 4.1. However, the small change in shape index (Shape Index = 4* *A/P
2 
where 
A is area and P is the perimeter) from 0.48 for control to 0.56 for cells exposed to 1000 
ng/ml for 20 min, indicated a tendency for cells to round up. 
 46 
           
 
 
 
 
                                          
 
 
 
Figure 4.5  Silver staining of HUVECs monolayer (512 X magnifications) (A) untreated 
or (B) treated with 0.1 ng/ml and (C) 1000 ng/ml alpha toxin. In case of control (A), few 
silver deposits (pointed with arrow) were found around the cells, while this number 
significantly increased in case of treated cells (B, C) 
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Figure 4.6  Schematic diagram showing the HUVEC monolayers prior to staining (A) 
and after staining along the contours of cell borders as well as the silver dots (B). To 
simplify, the gap area and the surrounding silver lines are shown in different colors. For 
the purpose of calculating the gap diameter (dg), two times the thickness of silver lines 
(dl) is subtracted from the diameter of silver deposit (ds)  
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Table 4.1  Effect of 20 min Exposure to Alpha Toxin on the Morphology of HUVECs.  
 
 Control Cells treated with alpha toxin for 
20 min 
  0.1 ng/ml 1000 ng/ml 
    
Cell Diameter ( m) 33.28 0.85 33.1  0.84 33.4     0.66 
Cell Perimeter 
( m) 
149.7  4.14 147.2 4.12 142.3  3.08 
Cell Area ( m
2
) 859.5    47.25 881.3     47.98 919.33  35.74 
Shape Index 0.48    0.01 0.51     0.01 0.56    0.008 
Minor Axis/Major 
Axis 
0.21      0.006 0.23     0.007 0.27      0.005 
# of Silver 
Deposits/ Cell 
0.435  0.08 0.84      0.184 4.44      0.314 
Gap Area (% of 
Total Area) 
0.04      0.007 
 
0.086    0.008 
 
0.41    0.02 
 
 
 
Values are means  SEM. For each condition, three set of experiments were carried out. 
During each of the studies, three independent images were photographed from randomly 
selected fields of view. Overall 90 cells (15 cells per image) were measured for each 
condition to calculate the mean values. 
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Figure 4.7 reveals a strong positive correlation between the sensor response and gap area 
(% of total area). The response of the biosensor to the presence of alpha toxin can thus be 
attributed to the formation of intercellular gaps upon exposure of cells to alpha toxin. 
Evidence of gap formation leading to the increased permeability of water and albumin on 
exposing confluent endothelial –cell monolayers to low doses of alpha toxin had been 
documented (Suttorp et al. 1985). Moreover, staphylococcal alpha toxin induced 
endothelial barrier function in isolated perfused rabbit lung and isolated rat ileum had 
also been reported (Brell et al. 2005; Seeger et al. 1990). Redistribution of junctional VE-
cadherin and occludin as well as slight F-actin stress fiber formation had been shown to 
accompany the intercellular gap formation when HUVECs were incubated with 
staphylococcal alpha toxin (Hocke et al. 2006). Other studies had reported that the initial 
binding of alpha toxin to the target cells in the water-soluble monomeric form is followed 
by oligomerisation to the heptameric structures. This leads to the formation of 
transmembrane pores (Bhakdi and J. 1991; Gouaux et al. 1994). These pores not only 
lead to the leakage of small molecules but also to an influx of calcium ions, which in turn 
trigger the arachidonate cascade (Bhakdi and J. 1991; Seeger et al. 1990; Suttorp et al. 
1985; Suttorp et al. 1987). It had been proposed that influx of calcium ions can initiate an 
interaction between the actin and myosin filament, which eventually leads to the 
contraction of the cells (Suttorp et al. 1988). 
 
4.4  Discussion 
The conventional method for detection of Staphylococcus aureus induced diseases 
involves the isolation and cultivation of the pathogen. Even though the method is reliable, 
it is time consuming. Moreover, the method lacks sensitivity once the antibiotic treatment 
has been initiated [12, 38]. Methods involving the detection of antibodies against 
staphylococcal antigens have been used for a long time. A more recent study performed 
ELISAs to measure the IgG antibodies against different antigens namely peptidoglycan, 
teichoic acid, alpha toxin, lipase, capsular polysaccharide, S. aureus ultrasonicate and 
whole S. aureus cells both separately and in combination. The aim was to evaluate their  
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Figure 4.7  Regression analysis between the gap area (% of total area) and the response 
obtained from the sensor upon exposure to different concentrations of alpha for 20 min 
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capability in distinguishing between uncomplicated and complicated S. aureus 
bacterimea, between S. aureus and non- S. aureus bacterimea and between S. aureus and 
non- S. aureus endocarditis (Ryding et al. 2002). No single assay was found to be suitable 
for the purpose. Two different combinations of ELISAs involving whole cells, teichoic 
acid, alpha toxin, lipase and capsular polysaccharide were only able to differentiate 
between S. aureus and non- S. aureus endocarditis (Ryding et al. 2002). There are many 
problems associated with antibody detection. Since the healthy individuals have 
antibodies against many staphylococcal antigens (Julander et al. 1983), detecting 
antibodies in the blood of patients is not sufficient. It is therefore important to detect 
unusually high levels of antibody titers for proper diagnosis. Hence, there is a 
requirement to define a cut off limit of the titer values to differentiate between a healthy 
individual and a patient. However, it had been observed that some patients having low 
titer values at the early stages of the disease showed a tendency of not generating high 
titers even with the progression of the disease (Mollby 1994). The other drawback 
associated with the antibody detection method is that a rise in serum antibodies against S. 
aureus antigens occurs after 7 – 30 days of onset of the infection (Christensson et al. 
1983; Julander et al. 1983). 
 On the contrary, staphylococcal antigens can be detected in the serum at the onset 
of the illness and also in the serum having low titer of antibodies. Detection of antigens 
can thus act as a valuable tool for the diagnosis of staphylococcal infections at the initial 
stages. Different assays have been employed to detect staphylococcal antigens like 
teichoic acid, muramic acid, alpha toxin, toxic shock syndrome toxin -1, various exo and 
enterotoxins and others (Christensson et al. 1989; Gehron et al. 1984; Loeffler et al. 1988; 
Rosten et al. 1987; Sarujballi and Fackrell 1984; Soderquist et al. 1993b). Alpha toxin, a 
protein exotoxin produced by the majority (85-90%) of S. aureus strains (Mollby 1983), 
plays a critical role in the pathogenicity induced by S. aureus.  As a matter of fact, it had 
been established, in animal models, that alpha toxin mutant or deficient S. aureus have 
diminished effect in inducing brain abscesses and keratitis (Kielian et al. 2001; Wu et al. 
2005c). Moreover, it had also been shown that immunization to alpha toxin can protect 
cornea from damaging during S. aureus keratitis (Hume et al. 2000). Studies describing 
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the physiological effects of alpha toxin had been reported (Bhakdi et al. 1988; Gemmell 
et al. 1982). 
 In this study, we reported the detection of staphylococcal alpha toxin using an 
endothelial cell based biosensor. The sensor is capable of detecting the presence of as low 
a concentration of alpha toxin as 0.1 ng/ml after only a 20 min exposure time. The 
response of the sensor can be attributed to the gap formation upon exposure of confluent 
HUVECs monolayer to varying concentration of alpha toxin. In fact, a strong positive 
correlation has been obtained between the sensor response and the area of the gap formed. 
The fact that this sensor requires only 20 min to measure the presence of alpha toxin 
together with its very low detection limit of 0.1 ng/ml bolsters its potential to act as a 
diagnostic tool during the onset of staphylococcal infections.  
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Chapter 5 : Measuring Permeability with a Whole Cell- Based Biosensor as an 
Alternate Assay for Angiogenesis: Comparison with Common in vitro Assays 
 
Based on studies published in: Ghosh, G., Mehta, I., Cornette, A., Anderson, K. W. 
“Measuring Permeability with a Whole Cell – Based Biosensor as an Alternate Assay for 
Angiogenesis: Comparison with Common in vitro Assays” Biosensors and Bioelectronics, 
2007, in Press 
5.1  Introduction 
Angiogenesis, sprouting of new blood vessels from the existing ones, under regulated 
conditions occurs in physiological functions like reproduction, wound repair as well as in 
muscle remodeling. Under pathological conditions, uncontrolled angiogenesis is observed 
in cancer, diabetes, arthritis, ocular neovascularization and several other diseases 
(Carmellet and Jain 2000; Folkman 1990; Reynolds et al. 1992). The angiogenic cascade 
consists of several distinct steps. Degradation of the basement membrane and 
extracellular matrix (ECM) and migration and proliferation of endothelial cells is 
followed by the organization of cells into three dimensional structures to form new 
capillaries as shown in Figure 5.1. Increased permeability plays an initial critical role in 
angiogenesis. Permeability increase results in the leakage of plasma proteins into the 
extracellular matrix thereby fostering the deposition of fibrin gel. Remodeled ECM 
further supports and helps in the development of new blood vessels (Bates et al. 2002; 
Dvorak et al. 1995).  
 Angiogenesis is regulated by the balance between pro and anti angiogenic 
molecules as shown in Figure 5.2. Several molecules have been classified as angiogenic 
factors based on their biologic activities (Folkman and Shing, 1992). Vascular endothelial 
growth factor (VEGF), basic fibroblast growth factor (bFGF), hepatocyte growth factor 
(HGF) and tumor necrosis factor- alpha (TNF-α) are some of the common potential 
regulators of angiogenesis, and these cytokines act simultaneously to activate 
angiogenesis in vivo (Asahara et al. 1995; Bond et al. 1998; Xin et al. 2001).  These 
angiogenic molecules are known to regulate different steps of angiogenesis by 
modulating permeability, proliferation, migration and tube formation of endothelial cells 
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Figure 5.1  Schematic of the angiogenic cascade. In response to the stimulus (cancer, 
wound healing etc), endothelial cells are activated leading to ECM degradation, cell 
migration and proliferation and eventually formation of capillaries. Modified from (Torry 
and Rongish 1992) 
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Figure 5.2  Angiogenesis is regulated by angiogenic inhibitor and stimulator.Disturbance 
in this equilibrium leads to different diseases 
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(Jiang et al. 1999; Lal et al. 2001; Morimoto et al. 1991; Naik et al. 2003; Nooteboom et 
al. 2000; Patterson et al. 1996; Rousseau et al. 2000; Wu et al. 2000). 
One of the most important challenges in the study of angiogenesis is the selection 
of an appropriate method for assessing this process.  While angiogenesis is best studied 
using in vivo assays, in vitro assays are preferred for initial screening of both pro-
angiogenic and anti-angiogenic molecules.  Common in vitro assays include analysis of 
cell migration, proliferation, and differentiation (Auerbach et al. 2003; Staton et al. 2004).   
Because increased cell permeability also plays a role in angiogenesis, the present study 
focused on the use of the whole cell-based biosensor that detects changes in cell 
monolayer permeability as an additional assay for quantifying angiogenesis.   
This study investigates the response of the sensor to both individual and combined 
cytokines that are known to stimulate angiogenesis, and this response is compared to 
other commonly used in vitro angiogenic assays including cell migration, cell 
proliferation and tube formation assays. 
 
5.2  Experimental Section 
 
5.2.1  Reagents 
 Purified carrier free VEGF165, bFGF, HGF and TNF-α were purchased from R&D 
Systems (Minneapolis, MN). The cytokines were dissolved in 0.1% bovine serum 
albumin (BSA) in Dulbecco’s phosphate-buffered saline (PBS) (GIBCOTM). Different 
concentrations of the cytokines studied were VEGF (1000 pg/ml), HGF (2000 pg/ml), 
bFGF (40 pg/ml) and TNF-α (100 pg/ml). These concentrations correspond to those 
found in serum of cancer patients (Dirix et al. 1997; Sezer et al. 2001). Basal medium 
consisted of EGM-2 supplemented with fetal bovine serum (FBS), ascorbic acid and 
gentamicin sulfate. Tube formation assay kit was purchased from Cell Biolabs Inc (San 
Diego, CA). HUVECs used during the experiments, were cultured as described in 
Chapter 3. Membrane materials and sensor preparation have also been described in 
Chapter 3. 
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5.2.2  Evaluation of Electrode Response for Permeability Studies  
Following confluent cell monolayer formation, the control membranes were tested for 
inhibited ion response. After the confirmation of the inhibited ion response due to the 
formation of the confluent monolayer, the cell-seeded membranes were exposed to 
different cytokine solutions containing individual and combinations of cytokines in PBS 
(pH 7.2), and the response of the sensor was measured. 
 At a final concentration of 0.1M KCl, the electrode response was measured for 
the following conditions: (a) the membrane without cells and without cytokines to obtain 
the baseline response of the sensor, (b) membranes without cells and with the  cytokines 
to test the effect of these angiogenic factors on the sensor alone, (c) membranes with cells 
and without cytokines to confirm the inhibited response of the sensor due to the confluent 
monolayer of cells, and (d) membranes with cells and with cytokines. 
To account for slight variations between fabricated membranes, the final data are 
reported as the ratio of the response obtained at 0.1 M KCl for the ISEs with HUVECs 
and cytokines to the response obtained for the same membrane without HUVECs and 
cytokines.  
 
5.2.3  Evaluation of Cell Migration 
 HUVECs were cultured in 24 well plates in complete medium and allowed to reach 
confluence. Once confluent, a wound was inflicted on the cell monolayer by scraping it 
with a sterile 200 µL pipette tip. The cell monolayer was washed three times, and the 
cells were then exposed to basal media with or without cytokines. Pictures were taken for 
times varying from t = 0 to t = 10 hrs to calculate the wound area using a Zeiss IM 35 
microscope. The percentage of wound closure was calculated as follows: 
100%
0,
,0,
x
A
AA
ClosureWound
tw
ttwtw
 
where Aw = area of wound 
Using the available software, AxioVision 4, the area of the wound was measured at 
different times. Three independent sets of experiments were carried out for each 
condition. Each experiment was replicated in two wells. Figure 5.3 demonstrates a 
schematic of the wound formation assay. 
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Figure 5.3  Schematic of the wound healing technique. As described in the procedure the 
confluent cell monolayer (a) was wounded by scraping (b) and then exposed to the 
angiogenic factors. The migration of the cells in the denuded area (c) led to the healing of 
wounds    
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5.2.4  Cell Proliferation Analysis 
 HUVECs seeded at cell density of 1x10
5
 cells/mL were cultured in complete media in 25 
cm
2 
culture flasks. After 24 h, the media was replaced by basal media with or without the 
cytokines. Following 48 h incubation, the cells were counted in a hemacytometer. Three 
independent sets of experiments were carried out for each condition. 
 
5.2.5  Tube Formation Assay  
 Tube formation experiments were carried out as directed by the kit manufacturer. 
Briefly, 50 µL of ECM gel was added to each well of the sterile 96 well plate and 
incubated for 30-45 min. A volume of 150µL of cell solution in basal media with or 
without cytokines was then added to each well. The cell density was maintained at 1x10
5
 
cells/well. After 11h, the extent of tube formation was examined under a Zeiss IM 35 
microscope and tube length was measured using Axiovision 4 software. Two independent 
sets of experiments were carried out for each condition. Each experiment was replicated 
in two wells. Figure 5.4 demonstrates a schematic representation of the tube formation 
assay. 
 
5.2.6  Statistical Analysis  
For all experiments, data are reported as mean  SEM. Statistical analyses were carried 
out using one-way ANOVA and the Student-Newman-Keuls test for post-hoc 
comparisons of the means with P<0.05. SigmaStat v 3.1 software was used for these 
analyses. 
5.3  Results 
 
5.3.1  Sensor Response to Individual Cytokines and Optimization of Exposure 
Time 
An important part of this investigation was to determine how long the sensor should be 
exposed to cytokines to obtain the optimum response.  To do this, the cell based ISE 
membranes were first exposed to 1000 pg/ml VEGF in PBS for times ranging from 30  
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Figure 5.4  Schematic representation of the tube formation assay. Cells seeded onto the 
ECM gel in 96 well plates (a) formed tubes (b) after 11 hrs of incubation with angiogenic 
factors 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ECM Gel 
 61 
min to 10 h and the response of the sensor to the presence of the VEGF was measured. 
Figure 5.5 illustrates the increase in overall response ratio with the increasing exposure 
time. The overall response ratio of the sensor increased from 0.08 to 0.43 on varying the 
exposure time from 30 min to 10 h. The results indicate that VEGF induced increase in 
HUVEC monolayer permeability initiated within 30 min of its addition and longer 
exposure times up to 10 h, resulted in further permeability enhancement. The cell based 
biosensor was then exposed to 100 pg/ml TNF-α in PBS for times ranging from 30 min to 
10 h. As shown in the figure, upon increasing the exposure time from 30 min to 3 h, the 
sensor response increased from 0.07 to 0.16. However, further exposure of the sensor to 
TNF-α resulted in a decrease in sensor response, indicating a decline in permeability of 
HUVEC monolayers. This result is consistent with a previous study which demonstrated 
a gradual decrease in HUVEC monolayer permeability after 6 h of exposure to TNF-α 
(Nooteboom et al. 2000). As shown in Figure 5.5, the sensor response dropped to 0.12 
after 5 h and 0.06 after 10 h. Thus, with TNF-α, permeability enhancement initiated after 
30 min of exposure with maximal change occurring after 3 h. 
 Since, the response of the sensor decreased after 3 h for TNF-α, it was decided 
that henceforth all the experiments would be carried out with a maximal exposure time of 
3 h. In addition, 30 min exposure time was eliminated since the sensor response to TNF-α 
and VEGF was minimal at this time compared to the response with cells only.  As shown, 
the response from the sensor to the presence of 2000 pg/ml HGF in PBS increased from 
0.08 to 0.16 as the exposure time increased from 1 to 3 h.  The cell based ISE membranes 
were then exposed to 40 pg/ml bFGF in PBS for 1 and 3 h. The sensor response increased 
from 0.07 to 0.1. These results agree with a previous study that demonstrated bFGF 
induced increase in HUVEC monolayer permeability (Stockton et al. 2004). 
To ensure that these cytokines do not affect the response of the sensor without 
cells, control experiments were performed where the ISE membranes without cells were 
exposed to cytokines for 3 h at the same concentration.  When the overall response 
obtained at 0.1 M KCl for the membrane exposed to the cytokines for 3 h was compared 
with that obtained for control, it was observed that more than 95% of the sensor response 
had been recovered as shown in Figure 5.6, indicating minimal protein adsorption on the 
sensor surface.  
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Figure 5.5  Ratio of ISE response obtained at 0.1 M KCl following exposure of the cell 
based sensor to different cytokines to ISE response obtained at 0.1 M KCl for the 
membrane without cells and without cytokines. (Error bars represent SE, N=3) 
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Figure 5.6  Ratio of ISE response obtained at 0.1 M KCl following exposure of the 
sensor to different cytokines in absence of cells to ISE response obtained at 0.1 M KCl 
for the membrane without cells and without cytokines. (Error bars represent SE, N=3.) 
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5.3.2  Sensor Response to Combination of Cytokines  
Once the response of the sensor to the presence of the individual cytokines had been 
measured, the biosensor was exposed to a combination of VEGF and TNF- α for 1 and 3 
h. Figure 5.7 illustrates the increase in sensor response indicating the modulation of 
monolayer permeability by the combination of cytokines. Even though an additive effect 
was not observed, the sensor response increased to 0.22 and 0.26 for the combined 
cytokines, as compared to 0.15 and 0.19 for VEGF and 0.14 and 0.16 for TNF- α, when 
exposed for 1 and 3 h, respectively. 
 The biosensor was then exposed to VEGF, TNF-α and HGF simultaneously for 1 
and 3 h. As shown in Figure 5.7, addition of HGF does not significantly change the 
response of the sensor from that obtained for the VEGF and TNF-α combination. Similar 
responses were obtained when the sensor was exposed to the combination of VEGF, 
TNF-α and bFGF, indicating that the addition of the third cytokine does not effectively 
improve the modulation of HUVEC monolayer permeability. 
 Next, the cell based ISE membranes were exposed to all four cytokines for 1 and 
3 h. Figure 5.7 illustrates the increase in sensor response indicating the enhancement of  
HUVEC monolayer permeability due to the combination of all four cytokines.  The 
sensor response increased to 0.32 and 0.42 for an exposure time of 1 and 3 h, respectively.  
 
5.3.3  Effect of Cytokines on Cell Migration 
Investigation of cell migration was carried out over times ranging from 0 to 10 h using 
the wound healing assay. Figure 5.8 shows the microscopic images of wound healing of 
cells when exposed to all four angiogenic factors. Figure 5.9A shows the increased 
percent wound closure with the increased exposure time. Significant difference in values 
between control and that induced by the individual or combination of cytokines was 
observed only after 10 h.  
 Figure 5.9B further illustrates the % wound closure when exposed to different 
cytokines for 10 h. Unlike TNF-α and VEGF, percentage wound closure induced by 
bFGF and HGF increased significantly as compared to the control. Combination of 
VEGF and TNF-α resulted in enhanced % wound healing compared to that induced by 
them individually. A previous study also reported a stimulatory effect of TNF-α on 
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Figure 5.7  Ratio of ISE response obtained at 0.1 M KCl following exposure of the cell 
based sensor to combinations of different cytokines for 1 and 3 hr to ISE response 
obtained at 0.1 M KCl for the membrane without cells and without cytokines. (Error bars 
represent SE, N=3.) 
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Figure 5.8  The microscopic images of wound induced in cells at time t = 0 (a) and 
healing of wound upon exposure to all four angiogenic factors after 10 hr (b) 
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Figure 5.9  (A) Percent of wound closure, incurred in HUVEC monolayers, in response 
to individual as well as combination of cytokines over the time ranging from 0 to 10 hr. 
(B) Comparisons of the effects of cytokines on wound healing after 10hr. (Error bars 
represent SE, N=3.) 
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VEGF induced wound healing (Giraudo et al. 1998). Addition of the third cytokine in the 
form of bFGF or HGF increased the % wound healing from that obtained when exposed 
to the combination of VEGF and TNF- α. However, no significant difference was 
observed between the combination of VEGF, TNF-α, bFGF and VEGF, TNF-α, HGF. 
When the cells were exposed to all four cytokines, a more profound closure of wound 
was observed.  Exposure to all four cytokines more than doubled the % wound healing 
when comparing with the control. 
 
5.3.4  Effect of Cytokines on Cell Proliferation 
The effects of the four cytokines on cell proliferation are shown in Figure 5.10.  The 
results showed that while bFGF showed no effect on proliferation, exposing the cells to 
VEGF and HGF for 48 h significantly increased cell proliferation. However, TNF- α 
actually inhibited proliferation.  In addition, it was observed that when HUVECs were 
incubated with both VEGF and TNF-α, TNF-α inhibited the effect of VEGF on HUVEC 
proliferation. The inhibitory effect of TNF-α and its ability to downregulate the mitogenic 
activity of VEGF has previously been documented in other studies (Frater-Schroder et al. 
1987; Nakagami et al. 2002; Patterson et al. 1996).  Adding bFGF and HGF to the 
VEGF/TNF- α solution did not significantly effect proliferation.  A previous study 
documented a synergistic effect of bFGF and VEGF in stimulating proliferation of bovine 
endothelial cells (Goto et al. 1993). However, our results show that in the presence of 
TNF-α, this synergistic effect does not occur indicating the TNF-α still inhibits the effects 
of VEGF on proliferation even in the presence of bFGF.  It is interesting to note, however, 
that when the cells were exposed to all four cytokines, a significant increase in 
proliferation is observed. 
 
5.3.5  Effect of Cytokines on Tube Formation 
The effects of the four cytokines on cell differentiation were investigated using the tube 
formation assay. Figure 5.11 shows the microscopic images of tube formation in the 
control studies (a) and when the HUVECs were treated with all four cytokines (b).Figure 
5.12 illustrates average length of tubes when the cells were exposed to both individual 
and combination of cytokines for 11 h. Stimulating cells with these individual cytokines  
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Figure 5.10  Proliferation of HUVEC in response to individual as well as combination of 
the cytokines. (Error bars represent SE, N=3.) 
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Figure 5.11  Microscopic images of tube formation in control studies (a) and after the 
cells are treated with all four angiogenic factors (b)  
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Figure 5.12  Average length of tubes formed upon exposing HUVEC to individual as 
well as combination of different cytokines for 11 h. (Error bars represent SE, N=2.)  
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did not result in significant increases in the length of tubes as compared to the control 
studies.  However, a significant increase in tube length was observed when HUVECs 
were cultured with both VEGF and TNF-α.  Adding bFGF or HGF to the VEGF/TNF-α 
solution did not increase the lengths of the tubes as compared to VEGF/TNF-α alone.  
Previous studies have reported a synergistic effect of VEGF and bFGF as well as the 
cooperative effect of VEGF, TNF-α and bFGF in inducing tubular structures in vitro 
(Koolwijk et al. 1996; Pepper et al. 1992). The difference in observation can be attributed 
to the difference in the cell lines used for the experiments. However, adding both bFGF 
and HGF to the VEGF/ TNF-α solution significantly increased the length of the tubes.   
 
5.3.6  Comparison Among Different Assays 
In order to carry out quantitative comparison among the different angiogenic assays, the 
responses of HUVECs to different cytokines were normalized. The normalized response 
is represented as the ratio of the responses to the stimulant to the responses obtained for 
control in that particular assay. The exposure time, at which significant difference in 
responses to the stimulant were obtained, were different for each assay.  In the case of 
cell monolayer permeability studies, the relative increase in sensor response was 
determined from the ratio of the overall sensor response after 1 h exposure to different 
cytokines to the response obtained from the untreated monolayers. In case of cell 
migration, proliferation and tube formation study responses after 10 h, 48 h and 11 h 
were considered, respectively. Figure 5.13 shows the normalized responses of the 
different assays when exposed to the individual cytokines and combinations of the 
cytokines. As demonstrated, a maximum of 1.75-fold increase in cell monolayer 
permeability was induced by bFGF. In other assays, it stimulated HUVECs to increase 
cell migration, proliferation and tube formation by 1.6, 1.1 and 1.06-fold the control 
value. Hence, at the concentrations studied, bFGF has almost an identical effect on all the 
steps of angiogenesis. Treating HUVECs with HGF resulted in increases of 2, 1.7, 1.4 
and 1.08-fold the control in permeability, migration, proliferation and tube formation 
respectively. Both TNF-α and VEGF showed a much greater effect on cell monolayer 
permeability as compared to the other steps of angiogenesis (3.2 and 3.75 times the 
control, respectively).  Effects on the other steps of angiogenesis ranged from a decreased  
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Figure 5.13  Relative increase, compared to control, of cell migration, proliferation, tube 
formation and permeability in response to individual as well as combination of different 
cytokines.  The exposure time, at which significant difference in responses to the 
stimulant were obtained, are different for each assay. In the case of cell monolayer 
permeability studies, the relative increase in sensor response was determined from the 
ratio of the overall sensor response after 1 h exposure to different cytokines to the 
response obtained from the untreated monolayers. In case of cell migration, proliferation 
and tube formation study responses after 10 h, 48 h and 11 h were considered, 
respectively 
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in cell proliferation when exposed to TNF-α to a 1.3-fold increase in cell proliferation 
and migration when exposed to VEGF.  Finally, combination of cytokines also showed 
large changes in cell monolayer permeability compared to the other steps of angiogenesis.  
For example, when exposed to all four cytokines, the permeability increased by 8-fold 
whereas tube formation, cell proliferation and cell migration only increased by 1.3, 1.6, 
and 2.1-fold, respectively.  When comparing these assays, it is important to remember 
that the exposure time at which significant differences in response to the stimulant were 
obtained differed for each assay.  However, the results clearly demonstrate that the 
permeability assay provided the most significant response in the quickest amount of time 
(only 1 h).   
 
5.4  Discussion 
Angiogenesis involves formation of new blood vessels from the existing ones. Pro- and 
anti-angiogenic molecules act in tandem to regulate angiogenesis. In diseases, it is this 
balance between the stimulators and inhibitors of angiogenesis that is disturbed. Several 
molecules have been classified as angiogenic factors based on their biological activities 
(Folkman and Shing 1992). Generally, multiple angiogenic factors are released in vivo 
and if one factor is insufficient in inducing any particular event of angiogenesis by itself, 
it can act in conjunction with other factors.  In addition, it has been shown that some 
factors can enhance the ability of other factors to induce the event. Different studies have 
demonstrated the combined effect of different growth factors on angiogenesis in vivo 
(Asahara et al. 1995; Bond et al. 1998; Xin et al. 2001). However, while in vivo analyses 
provide the most accurate representation of angiogenesis inside the body, it is not feasible 
to use in vivo analyses for initial screening of pro- and anti-angiogenic molecules.   One 
of the most important challenges in the study of angiogenesis is the selection of 
appropriate in vitro methods for assessing this process. Investigators have accepted the 
fact that a combination of assays is needed to truly assess the entire angiogenic process 
(Staton et al. 2004).   
Cell proliferation is one of the most common methods employed for assaying in 
vitro angiogenesis. Results from this investigation demonstrated that bFGF, HGF and 
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VEGF enhanced cell proliferation while TNF-α inhibited it. Upon incubating HUVECs 
with both VEGF and TNF-α, it was observed that TNF-α downregulated the ability of 
VEGF to stimulate cell proliferation. Previous studies had also reported similar 
observations (Frater-Schroder et al. 1987; Nakagami et al. 2002; Patterson et al. 1996). 
Even though incubating HUVECs with three different cytokines did not increase the 
proliferation in significant amount, incubation with all the four cytokines resulted in a 
significant increase in the mitogenic activity.  
Another in vitro technique commonly used to analyze angiogenesis is cell 
migration. Experiments with individual cytokines demonstrated that at the concentrations 
tested, bFGF and HGF produced maximum migration, followed by VEGF and TNF-α 
after 10 h. Incubating cells with combination of VEGF and TNF-α resulted in increased 
migration of HUVECs. Another study had also demonstrated wound healing induced by 
VEGF was enhanced by TNF-α (Giraudo et al. 1998). Profound wound healing was 
observed upon stimulating the cells with all four cytokines. 
Finally, morphogenesis or organization of cells into tubular structures is 
commonly used to assay angiogenesis. This investigation showed that exposing HUVECs 
to individual cytokines at the concentrations studied produced no significant changes in 
their ability to induce tube formation. However, previous studies had shown that unlike 
HGF, at higher concentrations (0.1 to 100 ng/ml) bFGF and VEGF stimulated tube 
formation (Kumar et al. 1998). Incubating cells with combination of VEGF and TNF-α 
resulted in significant increase in the average length of tubes. Further addition of the third 
cytokine did not increase the tube length significantly. Synergistic effect of VEGF and 
bFGF as well as the cooperative effect of VEGF, TNF-α and bFGF in inducing tubular 
structures in human microvascular endothelial cells have been reported previously 
(Koolwijk et al. 1996; Pepper et al. 1992).  However, incubating cells with all four 
cytokines enhanced tube formation.    
Another key initial step in the process of angiogenesis is increase in vascular 
permeability.  The effects of growth factors on endothelial cell permeability have been 
studied previously; however, the use of permeability as an assay for angiogenesis has not 
been investigated.  The present study focused on the use of a cell-based biosensor that 
detects changes in cell monolayer permeability as a possible assay for quantifying 
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angiogenesis.  Results demonstrated that the biosensor responded to the presence of 
VEGF as early as 30 min, and the overall sensor response increased with increasing 
exposure time up to 10 h. However, it was observed that exposing the sensor to TNF-α 
beyond 3 h resulted in a reduced sensor response indicating a decrease in cell monolayer 
permeability. This result is in agreement with another study which also reported a 
decrease in permeability after 6 h stimulation of HUVEC with TNF- α (Nooteboom et al. 
2000). The decrease in cell monolayer permeability can be either due to the 
internalization of cell surface receptors thereby resulting in reduced number of receptors 
for TNF-α to bind or due to release of phosphatases upon prolong exposure to TNF-α 
which thereby prevents phosphorylation of different signaling pathways (Lum and Malik 
1994). Even though bFGF and HGF were able to induce an increase in monolayer 
permeability, as evident from the increased sensor response, the responses of HUVEC 
monolayers to these growth factors were much less compared to that obtained for VEGF 
and TNF-α. 
Exposing the cell based sensor to the combination of VEGF and TNF-α resulted 
in an increased response from the sensor indicating the modulation of cell monolayer 
permeability by the combined effect of these two cytokines. However, addition of third 
factor in the form of bFGF or HGF did not increase the sensor response. When the sensor 
was exposed to the combination of all the four cytokines, a profound increase in sensor 
response was observed. To the best of our knowledge, only one study had previously 
been reported which investigated the effect of combining TNF-α, IFN-gamma and 
interleukin-1 alpha/beta on HUVEC monolayer permeability (Burke-Gaffney and Keenan 
1993).  
The changes in cell monolayer permeability and hence the increase in sensor 
response can be due to the weakening of cellular junctions leading to gap formation in the 
cell monolayer or can be due to the formation of caveolae like structure within cells 
which act as transcellular channels. Study directed towards elucidating the mechanism 
behind increased biosensor response has been described in Chapter 6. 
 To compare the permeability assay with the other commonly used in vitro assays, 
the responses obtained from each assay were normalized with respect to the control 
values.   This comparison demonstrated that the relative change in the permeability assay 
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in the presence of cytokines compared to the control was far greater than the relative 
change observed in other assays, especially when the cells were exposed to combinations 
of cytokines.  These results indicate that a permeability assay may be an alternative or at 
least additional method for screening both pro- and anti-angiogenic factors and may 
provide better sensitivity at lower concentrations of angiogenic factors.  In addition, 
while other in vitro angiogenic assays can take up to 10 - 48 h to complete, the cell based 
biosensor provided a response in only 1 h, bolstering its potential to act as a quick 
screening tool for angiogenesis.      
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Chapter 6 : Comparing the Effect of Different Cytokines on Endothelial and 
Epithelial Cell Architectures 
 
6.1  Introduction 
Epithelia as well as endothelia act as a selectively permeable barrier, whereby permitting 
the passage of water and nutrients while preventing the passage of pathogens. During 
several pathological conditions such as cancer, diabetes, Crohn’s disease and 
inflammatory bowel disease, the permeability properties of these cells are compromised 
(Clayburgh et al. 2004; Irvine and Marshall 2000; Rak et al. 2007; Scalia et al. 2007). 
Different angiogenic molecules such as vascular endothelial growth factor (VEGF), basic 
fibroblast growth factor (bFGF), hepatocyte growth factor (HGF) and tumor necrosis 
factor – alpha (TNF-α) are known to induce increased permeability across cell 
monolayers (Lal et al. 2001; Martin et al. 2002; McKay and Baird 1999; Mullin and 
Snock 1990; Nusrat et al. 2000; Stockton et al. 2004; Walsh et al. 2000; Wang et al. 
2005). This modulation of permeability can be attributed either to the altered rate of 
transport of solutes across the cells through transcellular channels (transcellular 
permeability) or through the gaps formed due to the disintegration of cell barrier 
architectures (paracellular permeability). Also, both pathways can contribute 
simultaneously to enhanced permeability across the cell monolayer. Figure 6.1 shows a 
schematic of these pathways which may be involved in increased permeability. Epithelial 
and endothelial cells maintain their flattened shape by counteracting the centrifugal 
tension generated by cellular junctions, focal adhesions and microtubules with the 
centripetal tension created by actinomyosin (Dudek and Garcia 2001; Mehta and Malik 
2006) as shown in Figure 6.2. The disruption of cell barrier integrity during increased 
paracellular permeability leads to changes in cell shape due to the disturbance of the 
equilibrium between the forces that help the cells maintain their morphology. Stimulation 
of cells with different cytokines has been shown to increase actin stress fiber formation 
and induce cell contraction (Dowrick et al. 1991; Morales-Ruiz et al. 2000; Petrache et al. 
2003; Stockton et al. 2004). Even though studies had shown that various actin binding 
proteins interact with intercellular junctional proteins as well as the cell - matrix binding  
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Figure 6.1  Schematic showing different permeability pathways. Permeability across cell 
monolayer can involve transcellular, paracellular or both pathways 
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Figure 6.2  Schematics showing cell-cell and cell- matrix adhesion 
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proteins, the effect of these agents on cell-substrate adhesion has not been studied in 
detail (Dudek and Garcia 2001; Lum and Malik 1994; Mehta and Malik 2006). The 
present study is carried out with the aim of i) investigating the effects of the above 
mentioned cytokines, individually and in combination, on the permeability properties of 
epithelial cells and comparing the effects with those on endothelial cells, ii) determining 
the mechanism (transcellular vs. paracellular) responsible for the changes in permeability 
and iii) studying the effect of these cytokines on cell – substrate adhesion. 
To compare the effects of VEGF, HGF, bFGF and TNF-α in inducing 
permeability across epithelial cell monolayers with those across endothelial cell 
monolayers, a confluent monolayer of LLC-PK1 was grown on the ISE membrane 
surface. LLC-PK1 is a well characterized porcine epithelial cell line having physiological 
properties very similar to the renal proximal tubule (Mullin and Kleinzeller 1985). 
Inflammatory cytokines like TNF-α had been shown to increase the permeability of LLC-
PK1 by altering the cell barrier integrity (Mullin and Snock 1990). This study is directed 
towards investigating the permeability modifying effects of both the individual and 
combined cytokines on the LLC-PK1 monolayer by measuring the responses from the 
LLC-PK1 based biosensor under these conditions and comparing these responses to those 
obtained from the HUVEC based biosensor. Further, to investigate whether the 
paracellular and transcellular pathway is involved in the induced permeability across the 
cell monolayer, the effect of these cytokines on the formation intercellular gaps as well as 
transcellular structures was studied for both the LLC-PK1 monolayer and the HUVEC 
monolayer. 
Studies have demonstrated that binding of cytokines to their respective cell 
receptors results in the activation of the signaling cascade eventually leading to increased 
permeability. Pathways implicated for increased permeability include the Raf-1-MEK-
ERK1/2 pathway and the NOS involved pathway (Breslin et al. 2003; Hu et al. 2005; Lal 
et al. 2001; Wu et al. 1999). As demonstrated in Figure 6.3, while protein kinase C (PKC)  
is the direct upstream mediator of Raf-1, both the PKC and Phosphatidylinositol 3 – 
Kinase (PI3-K) pathway are involved in NO induced permeability. PKC and PI3-K 
signaling pathways have been reported to regulate the cell – cell junctional proteins and 
have thus been implicated to play integral roles in cytokine mediated increase in  
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Figure 6.3  Schematic of signaling pathways. Binding of cytokines to the respective 
receptors leads to the activation of PI-3K and PKC. In turn, PKC can induce permeability 
by Raf1-MEK-ERK1/2 pathway or by activation of eNOS. PI-3K activation leads to the 
involvement of Akt –eNOS pathway for induction of permeability 
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paracellular permeability [Mullin 1990, Lal 2001, Breslin 2003, Hu 2005, Wu 1999].  
The present study also investigated the effect of blocking PKC and PI3-K, with 
LY294002 and Bisindolylmaleimide I (BIM I) respectively on the sensor response and 
the intercellular gap area for both the cell lines. 
 
6.2  Experimental Section 
 
6.2.1  Reagents  
Purified carrier free VEGF165, bFGF, HGF and TNF-α were purchased from R&D 
Systems (Minneapolis, MN). The cytokines were dissolved in 0.1% bovine serum 
albumin (BSA) in Dulbecco’s phosphate-buffered saline (PBS) (GIBCOTM). HUVECs 
and LLC-PK1 cells used during the experiments were cultured as described in Chapter 3. 
Membrane materials and sensor preparation have also been described in Chapter 3. 
 
6.2.2  Evaluation of Electrode Response 
 Following confluent cell monolayer formation, the control membranes were tested for 
inhibited ion response. After the confirmation of the inhibited ion response, the cell-
seeded membranes were exposed to different cytokine solutions containing individual 
and combinations of cytokines (pH 7.2) in PBS for 3 h, and the response of the sensor 
was measured. 
 At a final concentration of 0.1M KCl, the electrode response was measured for 
the following conditions: (a) the membrane without cells and without cytokines to obtain 
the baseline response of the sensor, (b) membranes with cells and without cytokines to 
confirm the inhibited response of the sensor due to the confluent monolayer of cells, and 
(c) membranes with cells and with cytokines.  
To account for slight variations between fabricated membranes, the final data are 
reported as the ratio of the response obtained at 0.1 M KCl for the ISEs with cells and 
cytokines to the response obtained for the same membrane without cells and cytokines.  
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6.2.3  Determination of Transcellular Structures 
To determine whether caveolae like structures leading to transcellular channels were 
formed in the cells upon exposure to the cytokines, the cells were examined under 
transmission electron microscope. For this purpose, the cells (both HUVECs and LLC-
PK1s) were cultured till confluency in petri dishes. Once confluent, the cells were treated 
with the combination of all four cytokines for 3 h. The cells were then rinsed with 0.1 M 
Sorenson’s phosphate buffer and fixed in 3.5% glutaraldehyde in 0.1 M Sorenson’s 
phosphate buffer for 45 min at 4 
0
C. Then, the cells were washed with 5% sucrose in 0.1 
M Sorenson’s buffer and post fixed with osmium tetra oxide in buffer for 45 min at  4 0C. 
The cells were then dehydrated in graded ethanol from 50% to 100% at room temperature. 
Next, they were embedded in resin, which was polymerized for 36 h at 60 
0
C. After 
hardening, thin sections (60 – 80 nm) were cut on a Reichert Ultracut E ultramicrotome 
with a diamond knife. They were stained initially with uranyl acetate for 5 min and then 
with lead citrate for 3 min and then examined with a Philips Tecnai 12 transmission 
electron microscope. 
 
6.2.4  Determination of Intercellular Gap Area 
Gap area determination by staining cells with coomassie blue had been described 
previously (Geldhof et al. 2002; Stockton et al. 2004). Briefly, a confluent monolayer of 
cells, cultured in 24 well plates, was treated with individual and different combinations of 
cytokines for 3 h. Cells were then rinsed with PBS and fixed for 30 min in 3% PFA in 
PBS. Following fixation, the cells were rinsed and stained with 0.25% coomassie blue in 
1:1:2 volume ratio of methanol: glacial acetic acid: deionized water for 10 min. The cells 
were then rinsed thoroughly with PBS. The air-dried cells were then examined under a 
Zeiss IM 35 microscope. The stained cells appeared dark and the intercellular gaps 
appeared white. For the purpose of determining the gap area using the Scion Image 
software, the images were inverted. As a result, the gap between the cells appeared black 
while the cells were white. The pixel values of the image ranged from 0 for white to 255 
for black. The total pixels corresponding to the image were counted. At different regions 
of the image, the threshold pixel value i.e. the pixel value corresponding to the beginning 
of gap area was determined. Total pixels greater than this value were then counted. From 
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this two pixel count, percent gap area was determined. Three independent set of 
experiments were carried out for each condition. Each experiment was replicated in two 
wells. 
 
6.2.5  Determination of the Effect of Blocking PKC and PI3-K Pathways 
To further investigate the role of the paracellular pathway in modifying permeability,  the 
PI3-K and PKC pathways were blocked with 0.01 nM LY294002 and 10 M BIM I, 
respectively. Studies have shown that BIM I and LY294002 at these concentrations can 
effectively block the PKC and PI3-K pathways effectively without inhibiting other 
protein kinases (Breslin et al. 2003; Lal et al. 2001). For this purpose, the effect of these 
inhibitors on sensor response as well as on the intercellular gap area was determined. To 
investigate the effect of blocking the pathways on sensor response, the electrode response 
was measured at a final concentration of 0.1 M KCl for the following conditions: (a) 
membranes with cells (HUVECs or LLC-PK1) and inhibitors but without cytokines, and 
(b) membranes with cells (HUVECs or LLC-PK1) and with cytokines and inhibitors. 
 To study the effect of blocking these pathways on paracellular permeability, 
intercellular gap area was determined as described earlier after treating the cells with 
inhibitors with or without the combination of all four cytokines. 
 
6.2.6  Determination of Cell- Substrate Adhesion 
To determine the effects of different cytokines on cell – substrate adhesion, cell surface 
area was measured following the method developed by Alexander and coworkers 
(Alexander et al. 2001). Briefly, confluent monolayers of cells, cultured in 24 well plates, 
were treated with individual and different combination of cytokines for 3 h. Following 
the treatment, the cells were rinsed and incubated with 0.1% trypsin in PBS for 5 min. 
The cells were rinsed again and fixed with 3% PFA for 30 min. Following fixation, the 
cells were rinsed and stained with coomassie blue for 10 min. To remove the excess dye, 
the cells were then rinsed and the air-dried cells were examined under a Zeiss IM 35 
microscope. The surface areas of the cells were then measured using Axio Vision 4 
software. Trypsinization leads to rounding up of cells resulting in reduced surface area. 
When the cell-substrate adhesion is increased, the cells resist rounding up following the 
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treatment with trypsin resulting in higher surface area (Alexander et al. 2001). Thus 
alteration in the cell-substrate adhesion is reflected in the altered surface area of cells. 
Three independent set of experiments were carried out for each condition. Each 
experiment was replicated in two wells. 
 
6.2.7  Statistical Analysis 
 For all experiments data are reported as mean  SEM. Statistical analyses were carried 
out using one-way ANOVA and the Student-Newman-Keuls test for post-hoc 
comparisons of the means with P<0.05. SigmaStat v 3.1 software was used for these 
analyses. 
 
6.3  Results 
 
6.3.1  Optimization of the Seeding Times 
In the case of the LLC-PK1 cell-based biosensor, the sensor response was initially 
evaluated as a function of seeding times of LLC-PK1. For this purpose calibration curves 
were constructed as shown in Figure 6.4. It was observed that increasing the seeding time 
from 5 h to 18 h resulted in reduced response from the sensor. However, further 
increasing the seeding time to 24 h, resulted in an increase in sensor response. 
Microscopic studies revealed that a confluent cell monolayer was formed within 18 h of 
seeding. Further incubation led to the cell death and detachment. Henceforth, for all the 
sensor experiments with epithelial cells, the incubation period of 18 h was maintained. 
 
6.3.2  Sensor Response in the Presence of Cytokines 
To evaluate the response from the sensor in the presence of different cytokines, the LLC-
PK1 cell-based sensor was exposed to four cytokines individually for 3 h. As seen in 
Figure 6.5, the response from the sensor significantly increased in the presence of these 
cytokines. When LLC-PK1 based biosensor was exposed to VEGF a response of 0.15  
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Figure 6.4  Calibration plots as a function of cell seeding times 
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Figure 6.5  Ratio of ISE response obtained at 0.1 M KCl following exposure of the cell 
based (HUVECs or LLC-PK1) sensor to the individual as well as combination of 
different cytokines for 3 hr to ISE response obtained at 0.1 M KCl for the membrane 
without cells and without cytokines. (Error bars represent SE N=3.) 
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was obtained. In case of TNF-α, HGF and bFGF the responses were 0.16, 0.14 and 0.09 
respectively. Next, the cell based sensor was exposed to different combination of these 
cytokines. Initially, upon exposing the sensor to the combination of VEGF and TNF-α 
(V+T) for 3 h, an enhanced response (0.22) from the sensor was obtained. Even though 
the response was not additive, it was significantly different from the responses obtained 
upon exposing the sensor to these cytokines individually. The sensor responses to the 
presence of the combinations of VEGF, TNF-α and HGF (V+T+H), VEGF, TNF-α and  
bFGF (V+T+b) and all four cytokines (V+T+b+H) were next evaluated. As demonstrated 
in Figure 6.4, the responses, 0.25, 0.22 and 0.27, respectively, were not significantly 
different from the response obtained for the combination of VEGF and TNF- α.  
 Upon comparing the epithelial cell based sensor with that of endothelial cell 
based sensor, no significant difference in the responses were observed when the cell 
based sensors were exposed to different cytokines individually. Thus while a response of 
0.15 was obtained from LLC-PK1 based biosensor in the presence of VEGF, the response 
from HUVEC based sensor was 0.19. In case of TNF-α, HGF and bFGF while for 
epithelial cell based biosensor the responses were 0.16, 0.14 and 0.09, respectively, the 
responses from HUVEC based sensor are 0.16, 0.16 and 0.1, respectively. However, 
when the responses to the combination of cytokines were compared, responses obtained 
from HUVEC based sensor was significantly greater than that obtained from LLC-PK1-
based sensor except in the case of combination of VEGF, TNF-α and HGF (V+T+H). For 
example, in the presence of all four cytokines, while a response of 0.42 was obtained 
from HUVEC based sensor, the response from the LLC-PK1 based sensor was 0.27. 
 
6.3.3  Determination of Permeability Pathway 
 Since we observed differences in the responses from the endothelial and epithelial cell 
based sensors, the next focus of this study was to determine the mechanisms behind the 
altered permeability in HUVEC as well as in LLC-PK1 monolayers. Increased 
permeability can be due to the disintegration of intercellular junctions leading to the gap 
formation between cells or due to the formation of caveolae acting as the transcellular 
channels. It is also possible that the passage of ions is due to both pathways acting 
simultaneously.  
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6.3.3.1  Determination of Caveolae 
Since, we obtained the maximum response from both the sensors in the presence of all 
the four cytokines, we decided to examine whether there is any caveolae formation when 
the cells were treated with the combination of all four cytokines. As observed in Figure 
6.6A, the number of caveolae in treated epithelial cells was much more than that 
observed in the control. However, as shown in Figure 6.6B, increases in the number of 
caveolae like structures were not observed in treated HUVECs as compared to the 
control. 
6.3.3.2  Determination of Intercellular Gap Area  
To observe the effect of different cytokines on intercellular gap formation, the cells were 
exposed to individual and combined cytokines for 3 h and gap area was determined. 
Figure 6.7 shows percent gap area upon exposing HUVEC and LLC-PK1 monolayers to 
different cytokines. With HUVECs, a 6% gap area was observed in the control. Exposing 
HUVECs to individual cytokines, except bFGF, resulted in significant increase in gap 
area. Treating with HGF and TNF-α individually caused a gap area of 16.5% and 16.9% 
respectively whereas treating with VEGF caused a gap area of 22%. When the cells were 
exposed to the combination of cytokines, percent gap area increased significantly as 
compared to individual cytokines. Treating with V+T, V+T+H and V+T+b caused  gap 
areas of 26.2%, 26.5% and 27.4%, respectively, whereas a profound increase in gap area 
to 43% was observed when HUVEC monolayer was treated with the combination of all 
the four cytokines. 
 In the case of LLC-PK1 cells, however, changes in gap area were not as profound. 
No significant difference in percent gap area from control was observed when the cells 
were treated with the cytokines individually. Thus, while a 2.4% gap area was observed 
in control, treating cells with VEGF, HGF, bFGF and TNF-α caused gap area of 3.99%, 
4.05%, 3.13% and 6.28% respectively. Exposure of cells to combinations of cytokines 
resulted in increase in gap area as compared to control. Treating the cells with V+T, 
V+T+H, V+T+b and V+T+H+b caused gap area of 7.15%, 7.04%, 7.52% and 8.5%, 
respectively.  
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Figure 6.6  Electron micrograph of LLC-PK1 (A) and HUVEC (B) cells with or without 
exposure to the combination of all four cytokines.  A significant increase in the density of 
caveolae like structures observed in treated LLC-PK1 as compared to control. In case of 
HUVEC, caveolae like structure formation did not increase significantly following 
treatment 
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Figure 6.7  Percent gap area formed in HUVEC and LLC-PK1 monolayer upon exposing 
to different individual and combination of cytokines for 3 h. (Error bars represent SE 
N=3.) 
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6.3.3.3  Correlating Percent Gap Area with Sensor Response 
 In Figure 6.8 the correlation between percent gap area and sensor response is shown. In 
the case of HUVECs, a strong positive correlation was obtained indicating that the sensor 
response can be attributed primarily to the formation of intercellular gaps. However, with  
LLC-PK1 cells, even though a positive correlation was observed it was not as great as 
that observed with the HUVECs indicating that the sensor response was not entirely due 
to the gaps formed between cells. These results also agree with the previous results 
showing more caveolae formed when treating LLC-PK1 cells indicating increases in 
transcellular permeability play a bigger role than increases in paracellular permeability 
when treating these cells with cytokines. In contrast, changes in paracellular permeability 
play a bigger role when treating HUVECs with these cytokines. 
 
6.3.3.4  Effect of Blocking Signaling Pathways on Sensor Response 
 Studies have reported that the cytokines have the ability to activate PI3-K and PKC in 
different cell lines. The activation leads to a series of downstream signaling which 
ultimately regulates intercellular proteins (Breslin et al. 2003; Hu et al. 2005; Lal et al. 
2001; Mullin and Snock 1990; Wu et al. 1999). Studies have also demonstrated that 
blocking PI3-K and PKC resulted in decrease in paracellular permeability induced by 
different cytokines across cell monolayers (Breslin et al. 2003; Hu et al. 2005; Lal et al. 
2001; Mullin and Snock 1990; Wu et al. 1999). The next part of this study was to observe 
the effect of blocking PI3-K by LY294002 and PKC by BIM I individually and then in 
combination on the sensor response. Figure 6.9 shows the effects of exposing the 
HUVEC based sensor to the inhibitors with or without the cytokines. When exposing the 
HUVEC based sensor to 0.1 nM LY294002 and 10 M BIM I individually and in 
combination, in the absence of the cytokines the responses were not significantly 
different from the response obtained without inhibitors. When exposing the cell based 
sensor to the combination of all four cytokines for 3 h in the presence of BIM I, a 
significant decrease in sensor response was obtained. A significant decrease in sensor 
response was also obtained when exposing the cells to LY294002 in the presence of 
cytokines. The responses thus obtained were 0.13 and 0.15 in the presence of BIM I and  
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Figure 6.8  Correlation between percent gap area and sensor response for HUVEC and 
LLC-PK1 
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Figure 6.9  Ratio of ISE response obtained at 0.1 M KCl following exposure of the 
HUVEC based sensor to the individual as well as combination of inhibitors with or 
without all four cytokines for 3 h to ISE response obtained at 0.1 M KCl for the 
membrane without cells and without cytokines. (Error bars represent SE N=3.) 
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LY294002 respectively. When exposing the HUVEC based sensor to all four cytokines in 
the presence of both these inhibitors, the response from the sensor decreased further and 
was comparable with the responses obtained for the controls. This indicates that both PI3-
K and PKC signaling pathways are simultaneously involved in the induction of 
permeability by these cytokines in HUVECs. This further supports our hypothesis that 
the increased response from the HUVEC based biosensor in the presence of cytokines is 
due to increased passage of potassium ions through the paracellular route. 
Figure 6.10 shows the effect of exposing the LLC-PK1 cell based sensor to the 
inhibitors with or without the cytokines. Similar to that observed with the HUVEC based 
sensor, no significant difference was observed in the responses when no cytokines were 
present. Upon exposing the sensor to BIM I in the presence of all four cytokines, the 
sensor response decreased significantly to 0.13, indicating that the PKC signaling 
pathway is involved in inducing permeability across the LLC-PK1 monolayer. Exposure 
to LY294002 led to a reduced response from sensor also, but it only reduced to 0.19. 
When exposing the sensor to all four cytokines in the presence of both inhibitors, the 
response (0.12) was not significantly different from that obtained upon exposing the 
sensor to BIM I alone. Hence, these observations indicate that the PKC signaling 
pathway is primarily involved in modulating permeability across the epithelial cell line. 
In addition, these results further support our hypothesis that in case of epithelial cells, 
both paracellular and transcellular pathways are simultaneously involved. 
 
6.3.3.5  Effect of Blocking Signaling Pathways on Intercellular Gap Area 
 To ensure that the attenuated sensor response in the presence of the inhibitors is due to 
reduced passage of ions through the paracellular route, the cell monolayers were exposed 
to these inhibitors with or without cytokines to observe their effect on gap formation. 
Figure 6.11 shows the effect of the inhibitors individually and in combination, on the 
percent gap area of the HUVEC monolayers. In the absence of the cytokines, the gaps 
formed between the cells in the various controls were not significantly different. 
Exposing the cells to the BIM I and LY294002 individually and both inhibitors 
simultaneously in the presence of all four cytokines reduced gap area significantly to  
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Figure 6.10  Ratio of ISE response obtained at 0.1 M KCl following exposure of the 
LLC-PK1 based sensor to the individual as well as combination of inhibitors with or 
without all four cytokines for 3 h to ISE response obtained at 0.1 M KCl for the 
membrane without cells and without cytokines. (Error bars represent SE N=3.) 
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Figure 6.11  Percent gap area formed in HUVEC monolayer upon exposing to individual 
as well as combination of inhibitors with or without all four cytokines for 3 h  (Error bars 
represent SE N=3.) 
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11.9%, 10.4 % and 7%, respectively, as compared to the 43% gap area obtained by  
treating the cells with these four cytokines in the absence of inhibitors. As observed, the 
gap area obtained in the presence of both the inhibitors and all four cytokines was not 
significantly different from that obtained in the control studies. 
 Similarly in case of LLC-PK1 cell monolayers, significantly reduced gap area was 
observed in the presence of the inhibitors as observed in Figure 6.12. The gap areas 
obtained in the presence of the inhibitors and the cytokines were comparable to that 
obtained in controls. 
 
6.3.4  Determination of Cell- Substrate Adhesion 
 In the case of both HUVEC and LLC-PK1 cells, the formation of gaps was observed 
between the cells indicating disruption of cell barrier integrity. This indicates that the 
balance between the tensile and contractile force that maintains the cell shape is disturbed. 
To determine whether the cell-substrate adhesion is altered to counteract the reduced cell- 
cell adhesion, we observed the effect of these cytokines on the surface area of trypsinized 
cells.  
 Figure 6.13 shows the effects of different cytokines on the surface area of the 
cells. Trypsinization results in rounding up of the cells which is evident from the reduced 
surface area of trypsinized as compared to the non-trypsinized cells in the absence of any 
cytokines. Treating cells with the individual cytokines, except TNF-α, for 3 hr did not 
significantly change the cell surface area of either the HUVEC or LLC-PK1 cells. 
However, when the cells were treated with the combination of cytokines, a significant 
increase in cell surface area was observed when compared to the control. As observed, 
the surface areas of trypsinized cells that had been treated with all four cytokines were 
836 and 797.8 m
2
 for the HUVEC and LLC-PK1 cells and significantly higher than the 
respective trypsinized cells (670.6 and 654.5 m
2
) in the absence of cytokines, indicating 
increased cell – substrate adhesion. 
 To determine whether the change in surface area correlates with the change in the 
intercellular gap area, percent increase in gap area was plotted against percent increase in 
surface area as shown in Figure 6.14. In both the cell types, a strong positive correlation 
was obtained between the two.  
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Figure 6.12  Percent gap area formed in LLC-PK1 monolayer upon exposing to 
individual as well as combination of inhibitors with or without all four cytokines for 3 h  
(Error bars represent SE N=3.) 
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Figure 6.13  Surface area of HUVEC and LLC-PK1 cells upon exposing to different 
individual and combination of cytokines for 3 h. (Error bars represent SE N=3.) 
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Figure 6.14  Correlation between percent increase in gap area and percent increase  in 
surface area for HUVEC and LLC-PK1 
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6.4  Discussion 
The present study investigated the effect of different cytokines on the permeability across 
LLC-PK1 monolayers using a cell based biosensor and compared the responses with 
those obtained from HUVEC based biosensor. Previous study with HUVEC based sensor 
showed that the sensor responded to the presence of VEGF, TNF-α, HGF and bFGF  
 (Ghosh et al. 2007b). When the sensor was exposed to the combination of these 
cytokines, the responses from the sensor increased especially when exposed to the 
combination of all four cytokines (Ghosh et al. 2007b).  Other studies have shown 
disruption of cell barrier integrity of different epithelial cells by different cytokines such 
as TNF-α, HGF, IL-13 and IFN-   leading to induction of increased permeability across 
the cell monolayer (McKay and Baird 1999; Mullin and Snock 1990; Nusrat et al. 1994; 
Nusrat et al. 2000; Sanders et al. 1995; Walsh et al. 2000; Wang et al. 2005). The barrier 
properties of LLC-PK1, the porcine epithelial cell line with properties very similar to the 
renal proximal tubule (Mullin and Kleinzeller 1985), are altered by different permeability 
modifying agents (Mullin and O'Brien 1986; Mullin and Snock 1990). The present study 
demonstrated that exposure of the epithelial cell based sensor to VEGF, TNF-α, HGF and 
bFGF resulted in enhanced sensor response indicating increase permeability across the 
LLC-PK1 cell monolayer. Exposing the sensor to different combinations of cytokines led 
to enhanced response from the sensor, indicating increased permeability in response to 
combination of cytokines. This observation is at par with an earlier study which had also 
demonstrated that IFN-  and TNF-α can synergistically disrupt the cell barrier integrity 
of Caco-2  cell monolayers (Wang et al. 2005).  
When comparing the epithelial cell based biosensor to the endothelial cell based 
biosensor it was shown that the responses obtained with the LLC-PK1 cells were less 
than that obtained with the HUVECs. The response from the sensor is due to the 
modulation of permeability by these cytokines. The differences in the sensor responses 
indicate that increased permeability induced across LLC-PK1 and HUVEC monolayer 
due to the cytokines is less with the LLC-PK1 cells as compared to the HUVECs. The 
mechanisms for increased permeability may involve either a transcellular pathway, 
paracellular pathway or both.  
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Caveolae, invaginations of plasma membrane, have been observed in most type of 
cells (Stan 2005) and different permeability modifying agents like VEGF and bFGF have 
been shown to increase the density of caveolae like structures both in vivo and in vitro 
(Chen et al. 2002; Esser et al. 1998b; Feng et al. 1999; Roberts and Palade 1997). The 
caveolae are then internalized and fuse together to form vesicles. The caveolae can thus 
act as transcellular channels for the transport of solutes or marker molecules. The electron 
microscopic study in the present case revealed an increased number of caveolae in LLC-
PK1 exposed to all four cytokines as compared to the control. The number of caveolae in 
HUVEC treated with same cytokines did not increase. This observation indicates that in 
the case of the epithelial cells, increase in permeability due to cytokines can be mediated 
through the transcellular pathway, however, in case of HUVECs, the increase in 
permeability may not involve the transcellular route.  
Significant increases in intercellular gap area were observed in the HUVEC 
monolayers treated with the cytokines as compared to control, indicating that the increase 
in permeability is mostly modulated through the paracellular pathway. Correlation 
between the sensor response and the percent gap area further confirms that the response 
from the sensor can be attributed to the formation of the gaps between cells in the 
presence of these cytokines. Other studies have also reported the formation of gaps in 
between the HUVECs leading to increased permeability, when treated with cytokines 
(Kevil et al. 1998; Nwaraiku et al. 2002; Stockton et al. 2004). Immunofluorescent 
staining of junctional proteins of HUVECs treated with VEGF or TNF-α revealed 
significant loss of VE – cadherin and occludin at the cell – cell junctions (Kevil et al. 
1998; Nwaraiku et al. 2002). Disorganization of the junctional proteins led to the 
formation of gaps between the cells. Another study suggested that the tyrosine 
phosphorylation of adherens junctional components resulted in weakening of cell-cell 
adhesions (Esser et al. 1998a). In the case of the LLC-PK1 monolayer, gap formation was 
also observed indicating the possibility of increased paracellular permeability. Previous 
studies had shown that increased permeability induced in LLC-PK1 by different 
stimulants like TNF-α and TPA occurs through paracellular pathway (Mullin and O'Brien 
1986; Mullin and Snock 1990). However, correlation between sensor response and gap 
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area was not great, indicating the gaps formed between LLC-PK1 cells are not solely 
responsible for increased sensor response. 
 Binding of cytokines to their respective receptors on the cell surface results in 
stimulation of several intercellular kinases like PI3-K and PKC. Activation of PI3-K and 
PKC triggers a series of reactions leading to the stimulation of downstream targets which 
eventually leads to the relaxation of tight junctions (Breslin et al. 2003; Hu et al. 2005; 
Lal et al. 2001; Mullin and Snock 1990; Potempa and Ridley 1998; Wu et al. 1999). 
Disintegrated cellular junctions results in an increase in paracellular permeability (Breslin 
et al. 2003; Hu et al. 2005; Lal et al. 2001; Mullin and Snock 1990; Wu et al. 1999). 
Exposure of the HUVEC based sensor to the combination of all four cytokines in the 
presence of each inhibitor resulted in significant reduction in sensor response. This 
observation matches closely with other studies which have demonstrated that blocking 
PI3-K and PKC by their respective inhibitors had abolished the enhancement of 
permeability induced by the stimulators (Breslin et al. 2003; Lal et al. 2001; Wu et al. 
1999). When the sensor was exposed to the cytokines in the presence of both the 
inhibitors, the response obtained was comparable to that obtained in the control. This 
shows that the permeability induced across HUVECs by the cytokines are mediated by 
both the PI3-K and PKC pathways and further supports our hypothesis that the response 
from the sensor can be attributed to the increase in paracellular permeability across 
HUVECs. Other studies have reported simultaneous activation of these pathways with 
VEGF and HGF induced permeability across endothelial cells [Lal 2001, Clermont 2006]. 
In the case of the LLC-PK1 based sensor, blocking the PKC pathway resulted in a 
significantly attenuated sensor response. Upon blocking the PI3-K pathway, the sensor 
response was not reduced as much as seen when blocking the PKC pathway. Blocking 
both pathways by treating with both inhibitors simultaneously did not significantly alter 
the response from that obtained when only PKC pathway was blocked. This observation 
demonstrates that in the case of LLC-PK1 cells, the increase in permeability induced by 
these cytokines is mostly mediated through PKC pathway. Other studies have also 
revealed that TNF-α and TPA induced permeability across LLC-PK1 monolayer is 
regulated by the PKC pathway (Clarke et al. 2000; Mullin and Snock 1990). The 
observation that the response obtained from the sensor in the presence of both the 
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inhibitors was significantly different from the control, further indicates that in case of 
LLC-PK1, permeability is not only mediated through the transcellular pathway but also 
the paracellular pathway. Moreover, treating the cells with the inhibitors of PKC and PI-
3K reduced the formation of gaps between cells indicating that the attenuated sensor 
response in the presence of the inhibitors was due to the reduction in gap area. With the 
HUVECs, both the gap area and the sensor response decreased to values comparable to 
the control when exposed to the cytokines and both inhibitors. This suggests that only the 
paracellular pathway is involved in increased permeability. However, with the LLC-PK1 
cells, even though the gap area reduced to that of control upon treating cells with both the 
inhibitors and all four cytokines, the sensor response was significantly different from the 
control. This further supports our hypothesis that cytokine induced increases in 
permeability are mediated through both the paracellular and the transcellular pathway.   
 Increase in intercellular gap area induced by the cytokines correlated well with the 
increase in cell surface area indicating that the cell barrier integrity is inversely related to 
the cell – matrix adhesion. Studies have also reported similar observations with lung 
microvascular endothelial cells treated with H2O2 (Alexander et al. 2001). Integrity of the 
cell monolayer is maintained by balancing the tensile cellular adhesion force with the 
contractile force generated by actin-myosin (Clayburgh et al. 2004; Irvine and Marshall 
2000). When the cell-cell adhesion is loosened, the equilibrium between the forces is 
disturbed. Cytokines have been reported to induce actin stress fiber formation in cells  
(Dowrick et al. 1991; Mehta and Malik 2006; Morales-Ruiz et al. 2000; Petrache et al. 
2003) as well as disruption of intercellular junctions (Esser et al. 1998a; Martin et al. 
2002; Mehta and Malik 2006; Nwaraiku et al. 2002). The cells maintain their 
morphology by counteracting the decrease in cell – cell adhesion force as well as the 
increase in actin generated contractile force by an increase in cell – matrix adhesion. This 
prevents cells from detaching from the substrate.  
 In summary, our studies revealed that VEGF, HGF, TNF-α and bFGF can induce 
permeability across the LLC-PK1 monolayer, both individually and in combination. The 
modulated permeability can take place through a combination of trans and paracellular 
routes. Moreover, paracellular permeability is primarily regulated by the PKC pathway. 
However, the change in permeability HUVECs by the cytokines is due to the formation 
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of the gaps and is regulated separately by PI3-K and PKC signaling pathways. Subjecting 
the cells to the cytokines, resulted in an increase in cell – matrix adhesion.  
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Chapter 7 : Biosensor Incorporating Cell Barrier Architectures on Ion Selective 
Electrodes for Early Screening of Cancer 
 
7.1  Introduction 
Millions of people die every year due to cancer all over the world, making it the second 
leading cause of death after heart disease. Such huge numbers of deaths can be attributed 
to the fact that in the absence of quick screening tools for cancer, in major cases, cancer 
is not diagnosed until the later stages of the disease. This, as a result, reduces the chances 
of successful therapy. According to American Cancer Society, early screening of cancer 
can reduce cancer related deaths by 50% by diagnosing an individual at the early stages 
of cancer and also by detecting individuals showing inclination to develop cancer. As a 
matter fact, mammography screening has been implicated for significant decrease in 
deaths of women suffering from breast cancer (Tabar et al. 2003). Moreover, recent years 
have witnessed profound decreases in mortality associated with uterine cancer due to 
increased screening using the Papanicolaou (Pap) test (Greenlee et al. 2000). Besides 
specificity and sensitivity, another factor that plays a critical role in screening cancer is 
the willingness of people to participate in a screening program. Increasing participation is 
generally observed in tests which are easy to perform and safe as compared to the 
complicated tests or tests which are uncomfortable and painful (Zitt et al. 2007). 
According to American Cancer Society, while 79% of American women 18 yr or older 
undergo PAP tests and 70% of women older than 40 yr undergo mammogram 
examination, only 40% of American women and men aged 50 yr or more take part in 
endoscopic screening, and only 20% participate in the fecal occult blood test (FOBT). 
Hence, recent research has been directed towards developing non-invasive techniques for 
early detection of cancer.   
Simplicity associated with the collection of blood samples has facilitated the 
development of diagnostic assays by using serum or plasma biomarkers. One such 
method is the detection of circulating tumor cells (CTC) in the peripheral blood of cancer 
patients. Studies demonstrated that detecting CTCs can be correlated with disease 
progression and therapeutic response (Denis et al. 1997; Muller et al. 2005; Nakagawa et 
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al. 2007; Sher et al. 2005). One major problem associated with this method is the 
discrepancies associated with the detection rates, which in turn may be due to the 
differences in the methods used for enrichment and detection of CTCs. Another non-
invasive method of cancer detection involves detection of DNA in the blood samples 
(Herrera et al. 2005; Silva et al. 2002). Studies have demonstrated the detection of 
genetic alterations such as mutations in the oncogenes and tumor suppressor genes, 
alterations in loss of heterozygosity (LOH) and microsatellite instability (MI), present in 
tumors, in the circulating DNA (Anker and Stroun 2001; Mulcahy et al. 1998; Shaw et al. 
2000; Silva et al. 1999). Another simpler approach involves the detection of total DNA 
concentration in plasma. Studies reported the increase in total DNA concentration in the 
plasma of cancer patients as compared to healthy individuals (Leon et al. 1977). However, 
posttranslational modifications which may be important in oncogenesis, can not be 
detected by this method of cancer detection (Kopf and Zharhary 2007). Since cancer is 
associated with altered expression of proteins and signaling pathways and eventually to 
altered levels of protein secretion in blood, detecting proteins in blood is a popular 
screening tool for cancer (Haab 2005; Kopf and Zharhary 2007; Nedelkov et al. 2006; 
Srinivas et al. 2002; Zangar et al. 2006). Some of the common and successful biomarkers 
include prostate specific antigen (PSA), cancer antigen 125 (CA-125) and 
carcinoembryonic antigen (CEA) mostly for prostate, breast and colorectal cancer. 
Detection and validation of these protein biomarkers depend mostly on traditional 
immunoassay methods such as ELISA or protein microarrays. These methods can be 
used to assay multiple proteins simultaneously and require less sample volumes. 
However, protein arrays are intrigued with several problems such as i) protein 
immobilization, ii) protein instability and denaturation, iii) need for highly specific 
antibodies and iv) problems associated with non specific binding (Sanchez-Carbayo 
2006). 
 One biological characteristic common to most cancers irrespective of origin is 
angiogenesis. To sustain beyond 2-3 mm size and to progress from benign to malignant 
state, tumors must recruit blood vessels from existing vasculature (Folkman 1995; 
Gimbrone et al. 1972). This in turn facilitates the metastasis or the spreading of cancer 
(Holmgren et al. 1995). Research has suggested that angiogenesis occurs during the 
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premalignant phase of tumor growth and inhibition leads to dormancy and ultimately 
death of cancer cells (Folkman 1985; Hanahan and Folkman 1996). Angiogenesis is 
regulated by the balance between pro and anti angiogenic molecules. Tumor angiogenesis 
is believed to stem from increased secretion of different angiogenic molecules such as 
vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), 
hepatocyte growth factor (HGF) and tumor necrosis factor- alpha (TNF- α) by tumor cells 
(Dunlop and Campbell 2000; Oppenheim and Fujiwara 1996). Increased secretion results 
in elevated levels of these molecules in the serum of cancer patients as compared to 
healthy individuals (Cronauer et al. 1997; Dirix et al. 1997; Granato et al. 2004; Heer et 
al. 2001; Marci et al. 2006; Premkumar et al. 2007; Sezer et al. 2001; Sheen-Chen et al. 
1997; Sliutz et al. 1995; Szlosarek et al. 2006; Ueno et al. 2001; Yoshida et al. 2002). 
 Since angiogenesis is not only common to most cancers but also occurs during the 
premalignant stage of cancer, we hypothesized that any physiological instrument having 
the ability to measure angiogenesis can act as a screening tool for cancer. A human 
umbilical vein endothelial cell (HUVEC) based biosensor has been developed in our 
laboratory, which takes the advantage of endothelial permeability dysfunction to detect 
small quantities of permeability modifying agents (Ghosh et al. 2007a; May et al. 2005; 
May et al. 2004a). The biosensor consists of a confluent monolayer of HUVEC seeded 
across the asymmetric cellulose triacetate (CTA) membrane of an ion selective electrode 
(ISE). In the presence of the confluent monolayer the passage of the marker ion, 
potassium, to the membrane surface is prevented, resulting in inhibited response from the 
sensor. When the permeability of the cell monolayer is altered by different permeability 
modifying agents, potassium ion reaches the membranes surface and hence the response 
from the sensor increased. The responses thus obtained can be related to the 
concentration of these agents (Ghosh et al. 2007a; May et al. 2005; May et al. 2004a).  
Earlier studies with this biosensor have shown that it has the potential to act as an 
alternate assay for measuring angiogenesis (Ghosh et al. 2007b). The study demonstrated 
that the biosensor responded to the presence of the above mentioned angiogenic 
molecules, both individually and in combination, at concentrations observed in the serum 
of cancer patients (Ghosh et al. 2007b). 
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 The present study is focused on measuring the responses of the sensor when 
exposed to the serum from healthy individuals and patients of different types and at 
different stages of cancer to explore the possibility of this biosensor to act as a quick 
screening tool for cancer. 
 
7.2  Experimental Section 
 
7.2.1  Reagents  
Purified carrier free VEGF165, bFGF, HGF and TNF-α were purchased from R&D 
Systems (Minneapolis, MN). The cytokines were dissolved in 0.1% bovine serum 
albumin (BSA) in Dulbecco’s phosphate- buffered saline (PBS) (GIBCOTM). Serum 
samples from healthy individuals and stage III pancreatic cancer patients were obtained 
from Bioreclamation (Hicksville, NY). All the remaining cancer serum samples i.e. 
serum samples from stage 0, I, III and IV of breast cancer patients and stage I of ovarian 
and lung cancer patients were obtained from Asterand (Detroit, MI). Informations 
regarding the age of the subjects, presence of steroid receptors (estrogen and 
progesterone), clinical diagnostics etc were obtained.  HUVECs used during the 
experiments, were cultured as described in Chapter 3. Membrane materials and sensor 
preparation had also been described in Chapter 3. 
 
7.2.2  Evaluation of Electrode Response 
 Following confluent cell monolayer formation, the control membranes were tested for 
inhibited ion response. After the confirmation of the inhibited ion response due to the 
formation of the confluent monolayer, the cell-seeded membranes were exposed to 
different cytokine solutions containing individual and combinations of cytokines (pH 7.2) 
in PBS for 1 and 3 hr and the response of the sensor was measured. The responses of the 
sensor to cytokines at concentrations found in serum of healthy individuals (i.e., 100 
pg/ml VEGF, 500 pg/ml HGF, 5 pg/ml bFGF  and 10 pg/ml TNF-α) were compared to 
the responses when exposed to the cytokines at concentrations found in the serum of 
cancer patients (i.e., 1000 pg/ml VEGF, 2000 pg/ml HGF, 40 pg/ml bFGF and 100 pg/ml 
 112 
TNF- α ) (Dirix et al. 1997; Sezer et al. 2001). The cytokines were dissolved in 0.1% 
BSA in PBS for these experiments. After confirming that the biosensor is able to 
differentiate between the different concentrations of cytokines i.e. the concentrations of 
cytokines corresponding to that observed in the serum of healthy individuals and in 
cancer patients, the responses were measured by exposing the cell based biosensor to 
actual serum samples from healthy individuals and cancer patients at different stages.  
At a final concentration of 0.1 M KCl, the electrode response was measured for 
the following conditions: (a) the membrane without cells and without cytokines/serum to 
obtain the baseline response of the sensor (b) membranes with cells and without 
cytokines/serum to confirm the inhibited response of the sensor due to the confluent 
monolayer of cells, (c) membranes with cells and with cytokines, (e) membrane without 
cells and with serum to test the effect of serum on the membrane of the sensor and (f) 
membrane with cells and with serum samples. 
To account for slight variations between fabricated membranes, the final data are 
reported as the ratio of the response obtained at 0.1 M KCl for the ISEs with HUVECs 
and cytokines/serum to the response obtained for the same membrane without HUVECs 
and cytokines/serum.  
 
7.2.3  Statistical Analysis  
For all experiments data are reported as mean  SEM. Statistical analyses were carried 
out using one-way ANOVA and the Student-Newman-Keuls test for post-hoc 
comparisons of the means with P<0.05. SigmaStat v 3.1 software was used for these 
analyses. 
7.3  Results 
 
7.3.1  Biosensor Response to the Different Cytokines in PBS 
Earlier studies demonstrated that exposing the cell based sensor to individual and 
combined cytokines at concentrations observed in the serum of cancer patients for 1 and 
3 h resulted in significantly increased response from the sensor (Ghosh et al. 2007b). In 
the present study, initially the biosensor was exposed to the cytokines individually and in 
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same combination but at concentrations observed in the serum of healthy individuals for 
1 and 3 h and compared to responses obtained when exposing the sensor to cytokines at 
concentrations found in cancer patients. As shown in Figure 7.1A, the biosensor 
responded to the presence of the individual cytokines at concentrations found in healthy 
individuals. The response from the sensor to the individual cytokines after 1 h exposure 
time was not significantly different from the value obtained to cells only except for 
VEGF. Upon exposing the biosensor to VEGF, HGF and TNF-α individually for 3 h, a 
response ratio of around 0.1 was obtained, which was significantly different from that of 
cells only. Upon exposing the cell based biosensor to the combination of cytokines VEGF 
and TNF-α (V+T), VEGF, TNF-α and HGF (V+T+H) and VEGF, TNF-α and bFGF 
(V+T+b) for 1 and 3 h, even though additive response was not obtained, the responses 
obtained in the presence of combined cytokines were higher than those obtained by 
exposing the sensor to individual cytokines. Upon exposing the cell based sensor to the 
combination of all four cytokines (V+T+ b +H) for 1 and 3 h profound increases in the 
sensor response to 0.12 and 0.17, respectively were obtained.  
Figure 7.1B shows the responses obtained by exposing the sensor to these 
cytokines at concentrations observed in the serum of cancer patients. The response from 
the sensor to the individual cytokines was higher than the response obtained at 
concentrations corresponding to healthy individuals. For example, exposure of the cell-
based biosensor to 1000 pg/ml VEGF for 3 h resulted in a response ratio of 0.19. When 
the sensor was exposed to 100 pg/ml VEGF for 3 h, a response ratio of 0.11 was obtained. 
Exposing the sensor to the combination of cytokines resulted in profound increase in 
sensor response as compared to the responses obtained from individual cytokines. 
Since all the cytokines are elevated during cancer, it was important to compare the 
responses from the sensor to the presence of all four cytokines cytokines, at 
concentrations corresponding to healthy individuals and cancer patients. This comparison 
is illustrated in Figure 7.2.  As can be seen, the sensor was able to differentiate between 
the two concentrations at both 1 and 3 h exposure times. Since, even for 1 h exposure 
time, significant differences were observed between the responses at the two different 
concentrations, it was decided for the serum studies, the responses would be measured 
using an exposure time of 1 h. 
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A: 
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Figure 7.1  Comparison of the ISE sensor responses obtained following exposure of the 
sensor to individual and combination of cytokines at concentrations observed in the 
serum of healthy individuals (A) and cancer patients (B) for 1 and 3 h. Total response 
ratio is defined as the ratio of the responses of cell-based sensor with or without 
cytokines to ISE response obtained at 0.1 M KCl for the membrane without cells and 
without cytokines. (Error bars represent SE N=3) 
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Figure 7.2  Comparison of the ISE sensor responses obtained following exposure to the 
combination of all four cytokines at concentrations observed in the serum of healthy 
individuals and cancer patients for 1 and 3 h. Total response ratio is defined as the ratio 
of the responses of cell-based sensor with cytokines to ISE response obtained at 0.1 M 
KCl for the membrane without cells and without cytokines. (Error bars represent SE N=3) 
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7.3.2  Biosensor Response to the Serum of Healthy Individuals 
Prior to exposing the cell-based biosensor to serum samples, it was important to 
investigate the effect of serum on the membrane of the biosensor. To do this, the sensor 
without any cells was exposed to the serum of healthy individuals for 1 h. Figure 7.3 
compares the response profiles of the sensor without cells and with and without serum. 
As seen, the response profiles with and without serum matched very close to each other. 
When the overall response obtained at 0.1 M KCl for the membrane exposed to the serum 
for 1 h was compared with that obtained for control, it was observed that more than 95% 
of the sensor response had been recovered, indicating that the serum does not effect the 
membrane surface. 
 Since the average response ratio of 0.12 was obtained by exposing the biosensor 
to the combination of the maximum concentration of the four cytokines observed in the 
serum of healthy individuals, it acted as our maximum cut off limit for healthy 
individuals. Next, the cell-based biosensor was exposed to 15 serum samples from 
healthy individuals for 1 h. Figure 7.4 demonstrates the responses obtained from the 
biosensor. As shown, the responses obtained for all the samples were less than 0.12. The 
responses ranged from 0.06 to 0.11 with the mean of 0.09. No significant differences 
were observed when comparing gender and age (p > 0.05). 
 
7.3.3  Biosensor Response to the Serum of Cancer Patients 
The biosensor was then exposed to the serum samples of pancreatic, breast, ovarian and 
liver cancer patients. Figure 7.5 shows the responses of the sensor to different cancer 
samples. As observed, in all the cases except one, the responses were above the 
maximum cut off limit for healthy individuals.  The sample for which a lower response 
was obtained corresponds to a stage 0 of breast cancer patient. 
Figure 7.6 illustrates the responses obtained from the biosensor when exposed to 
the serum samples from stage III of both breast and pancreatic cancer patients and 
healthy individuals. When comparing these results, it was observed that the responses for 
cancer patients were significantly higher than those obtained for healthy individuals. 
However, no significant difference was obtained between the responses for the cancer  
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Figure 7.3  Response vs. log K
+
 plot for the ISE membranes (A) without cells and 
without serum and (B) without cells and exposed to serum from healthy individuals for 1 
hr. This plot represents one experiment. The experiment was repeated two more times 
giving similar results 
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Figure 7.4  Response ratios obtained when exposing the sensor to the serum of healthy 
individuals for 1 h. Serum samples from 15 healthy individuals were used in these 
experiments and each point represents one individual. Each serum sample was measured 
three times. Total response ratio is defined as the ratio of the responses of cell-based 
sensor with serum to ISE response obtained at 0.1 M KCl for the membrane without cells 
and without serum. (Error bars represent SE) 
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Figure 7.5  Response ratios obtained when exposing the sensor to the serum of cancer 
patients for 1 h and compared to the responses obtained from healthy individuals. Total 
response ratio is defined as the ratio of the responses of cell-based sensor with serum to 
ISE response obtained at 0.1 M KCl for the membrane without cells and without serum. 
A total of 23 cancer patients were used in this study and each point represents one patient. 
Each serum sample from cancer patients was measured once 
 
 
 
 
 
 
 
 
 
 
 
 
 120 
0
0.05
0.1
0.15
0.2
0.25
0.3
Healthy Breast Cancer Pancreatic Cancer 
ISE Experiments
T
o
ta
l 
R
e
s
p
o
n
s
e
 R
a
ti
o
 
 
Figure 7.6  Response ratio obtained when exposing the sensor to the serum of stage III 
pancreatic and breast cancer patients for 1 h and compared to the responses obtained from 
healthy individuals. Total response ratio is defined as the ratio of the responses of cell-
based sensor with serum to ISE response obtained at 0.1 M KCl for the membrane 
without cells and without serum. The values represent the mean of 15 healthy individuals, 
3 breast cancer and 5 pancreatic cancer patients 
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from the different organs. This indicates that the biosensor is able to differentiate between 
healthy individuals and cancer patients at stage III, but does not distinguish between the 
two cancer types. 
 To explore the ability of the biosensor to act as an early screening tool for cancer, 
it was next exposed to the serum samples from stage 0 and I of breast cancer patients and 
compared with the later stages of breast cancer. As shown in Figure 7.7, the responses 
obtained from the biosensor were significantly higher when exposed to serum from stage 
I breast cancer patients than those of the healthy individuals. When the biosensor was  
exposed to serum of stage 0 breast cancer patients, the average response obtained was 
very close to the maximum cut off limit for healthy individuals (0.13 vs. 0.12). However, 
when comparing these responses to the average responses from the healthy individuals, a 
significant difference between the two were obtained. The responses obtained at stage 0 
and stage I were not significantly different from each other. To further confirm the ability 
of the biosensor to act as the early screening tool of cancer, the biosensor was exposed to 
the stage I serum samples from ovarian and liver cancer patients and compared to those 
obtained from stage I breast cancer patients and healthy individuals. As shown in Figure 
7.8, significant differences were observed between the responses to cancer patients 
irrespective of cancer origin and healthy individuals indicating the potential of the 
biosensor to act as early screening tool for cancer. However, no significant differences 
were observed (p > 0.05) in the responses for the cancers from the three different organs. 
 To further compare the sensor response to samples from healthy individuals to 
those obtained from cancer patients, responses from the stage 0 and I of different cancer 
types were coupled together as early stage while  responses from stages III and IV were 
couples together as the later stage of cancer. These results shown in Figure 7.9 
demonstrate that significant differences were obtained when comparing the responses 
from healthy individuals to the responses from the early and later stages of cancer. In 
addition, significant differences were obtained when comparing the early and later stages 
of cancer. This shows that the biosensor is not only able to act as an early screening tool 
for cancer but can also differentiate between early and later stage of the disease. 
 
 
 122 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
Healthy Stage 0 Stage I Stage III Stage IV
ISE Experiments
T
o
ta
l 
R
e
s
p
o
n
s
e
 R
a
ti
o
 
 
Figure 7.7  Response ratios obtained when exposing the sensor to the serum of different 
stages of breast cancer patients for 1 h and compared to the responses obtained from 
healthy individuals. Total response ratio is defined as the ratio of the responses of cell-
based sensor with serum to ISE response obtained at 0.1 M KCl for the membrane 
without cells and without serum. The values represent the mean of 15 healthy individuals 
and 3 each of different stages 
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Figure 7.8  Response ratios obtained when exposing the sensor to the serum of stage I 
breast, ovarian and liver cancer patients for 1 h and compared to the responses obtained 
from healthy individuals. Total response ratio is defined as the ratio of the responses of 
cell-based sensor with serum to ISE response obtained at 0.1 M KCl for the membrane 
without cells and without serum. The values represent the mean of 15 healthy individuals 
and 3 each of different cancer types 
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Figure 7.9  Response ratios obtained when exposing the sensor to the serum of early and 
later stages of cancer patients for 1 h and compared to the responses obtained from 
healthy individuals. Total response ratio is defined as the ratio of the responses of cell-
based sensor with serum to ISE response obtained at 0.1 M KCl for the membrane 
without cells and without serum. Stage 0 and I cancer patients were coupled together as 
early stage and stage III and IV corresponds to the later stages of cancer. The values 
represent the mean of 15 healthy individuals and 12 early stages and 11 later stages of 
cancer 
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7.4  Discussion  
It is well known that screening can significantly reduce cancer morbidity. Firstly, by 
diagnosing an individual at the early stages of cancer, screening increases the chances of 
successful therapy. Secondly, by diagnosing abnormal cells or lesions, screening can help 
identify an individual showing an inclination to develop cancer and thus reduce the 
morbidity of cancer treatment. Research has shown that people are more willing to 
participate in easy to perform screening tests like blood tests as opposed to complicated 
or painful screening examinations like endoscopy or mammeograms. Moreover, the fact 
that beyond 50 yr of age an individual has to undergo a number of tests to ascertain the 
healthy status also reduces one’s willingness to participate in screening programs. For 
example, a woman 50 yr or more in age has to undergo mammeogram, endoscopic 
examinations as well as Pap tests to be certain that she is not suffering from breast, colon 
or uterine cancer. Similarly, a man 50 yr or more in age should undergo endoscopic 
examination for screening colon cancer and also digital rectal examination and PSA 
testing for prostate cancer. Hence, there exists a need for not only a non -invasive 
diagnostic tool for cancer but a tool which can identify patients suffering from cancer 
irrespective of origin. This has encouraged research in detection and validation of 
biomarkers for cancer. Biomarkers are biological molecules which are present at different 
concentrations in healthy individuals and in cancer patients (Srinivas et al. 2001). Some 
common biomarkers are circulating tumor cells (CTCs), circulating DNA and proteins. 
Differences in enrichment and detection method of CTCs translate into major 
discrepancies in detection rates of CTCs which in turn act as a major drawback for this 
cancer detection method. However, proteomics score over genomics for biomarker 
detection and screening cancer due to the ability to take into account the posttranslational 
modifications, differential splicing of mRNAs and functional regulation of gene 
expression (Eyk 2001). Since there are hundreds of proteins with significantly different 
concentrations in healthy individuals and in cancer patients, a device will have a better 
potential to act as a screening tool if it can detect a combination of proteins rather than an 
individual protein. However, the major challenge lies in selecting proteins, individually 
or in combinations, which will be successful in acting as biomarkers. 
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Angiogenesis is a biological characteristic that is common to most cancers 
irrespective of their origin. For a cancer to progress from its benign state to a malignant 
state, recruitment of blood vessels from the existing vasculature is required (Folkman 
1995; Gimbrone et al. 1972). This leads to increased secretion of cytokines into the blood 
such as VEGF, HGF, TNF-α and bFGF into the serum of cancer patients as compared to 
healthy individuals (Cronauer et al. 1997; Dirix et al. 1997; Granato et al. 2004; Heer et 
al. 2001; Marci et al. 2006; Premkumar et al. 2007; Sezer et al. 2001; Sheen-Chen et al. 
1997; Sliutz et al. 1995; Szlosarek et al. 2006; Ueno et al. 2001; Yoshida et al. 2002). The 
concentrations of these cytokines can be measured by ELISA. Multiplexed technology 
enables one to measure several of these cytokines simultaneously but individually. 
However, concentration of these cytokines in the serum of cancer patients can vary not 
only on the basis of cancer origin and stages but also from person to person suffering 
from cancer in same organ and also at the same stages. Moreover, at the early stages of 
cancer, the concentrations of all the cytokines are not elevated simultaneously. Hence, 
any physiological tool which can detect combination of cytokines will be a better 
screening tool as compared to a device which measures several of the individual 
cytokines simultaneously. 
 A whole cell based biosensor has been developed in our laboratory which takes 
the advantage of endothelial cell barrier dysfunction to detect small quantities of 
permeability modifying agents (Ghosh et al. 2007a; May et al. 2005; May et al. 2004b). 
Earlier studies with this biosensor showed that by measuring increases in cell 
permeability induced by the cytokines such as VEGF, HGF, bFGF and TNF-α, it can act 
as an alternate assay for measuring angiogenesis. The concentrations of the cytokines 
used were those generally observed in the serum of cancer patients (Dirix et al. 1997; 
Sezer et al. 2001). In this study we showed that upon exposing the sensor to the same 
cytokines individually and in combinations but at concentrations observed in the serum of 
healthy individuals, lower responses were obtained from the sensor, indicating a dose 
dependant response of the sensor to the presence of these cytokines. Comparing the 
biosensor response to the combination of all four cytokines at concentrations observed in 
the serum of healthy individuals and cancer patients, it was observed that the biosensor 
was able to differentiate between the two concentrations. Further it was shown that a 
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response from the sensor can be obtained in only 1 h as compared to ELISA which 
requires 4-6 h.   
When the biosensor was exposed to the serum samples from 15 different healthy 
individuals, the responses varied from 0.06 to 0.11 with a mean of about 0.09. The 
biosensor was then exposed to the serum samples from the patients suffering from 
pancreatic, breast, ovarian and liver cancer. The results demonstrated that the responses 
of the biosensor to different cancer samples irrespective of the stages were significantly 
higher than the responses for healthy individuals.  Upon comparing the responses for 
different stages of breast cancer patients to healthy individuals, significant differences 
between the responses were obtained. Moreover, when the responses of the sensor to 
different stage I cancer patients were compared with healthy subjects, it was observed 
that irrespective of the origin, the responses of the sensor to cancer patients were higher 
than those for healthy individuals. Finally, stage 0 and I cancer were coupled together as 
the early stage and stage III and IV as the later stages of cancer and the responses of early 
and later stages of cancer were compared with healthy individuals. The results indicate 
that the sensor was able to differentiate early stages of cancer patients irrespective of the 
origin from the healthy individuals. The present study demonstrates that the biosensor 
can not only distinguish between healthy individuals and cancer patients, but responses 
from the sensor correlates with the stages of cancer. 
 In summary, these initial studies indicate the endothelial cell based biosensor can 
differentiate healthy subjects from patients both at early and later stages of cancer within 
1 h. Further studies with additional blood samples are needed to further confirm its 
potential to act as a screening tool for cancer. 
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Chapter 8 : Conclusions 
 
The study was directed towards investigating the ability of a cell -based biosensor to 
monitor physiological toxins and to screen cancer. This chapter summarizes the 
conclusions from the different studies. 
 Exposing the HUVEC -based biosensor to the physiological toxin, staphylococcal 
alpha toxin, led to the alteration of permeability across the cell monolayers. This resulted 
in increased response from the sensor. The study demonstrated: 
 
 Increasing the time of exposure of the cell based sensor to 1000 ng/ml alpha toxin 
for time ranging from 10 to 90 min resulted in increased overall response with 
time. 
 Microscopic studies revealed detachment of cells upon prolonged exposure. 
Optimal exposure time of the sensor to the toxin was found to be 20 min. 
 The biosensor responded to alpha toxin at concentration ranging from 0.1 to 1000 
ng/ml. 
 Minimum detectable limit of alpha toxin by the biosensor was found to be 0.1 
ng/ml. Considering the fact that the toxic concentration of alpha toxin in humans 
is 100 -250 ng/ml of whole blood, this biosensor has the potential to act as a 
diagnostic tool at the onset of staphylococcal diseases. 
 Silver staining of HUVECs treated with alpha toxin revealed formation of gaps 
between the cells. Percentage of gap area increased with increasing concentration 
of the toxin. 
 
The HUVEC based biosensor was used to measure permeability as an alternate assay for 
angiogenesis. The cell based biosensor was exposed to VEGF, bFGF, HGF and TNF-α 
individually and in combination at the concentration observed in the serum of cancer 
patients. The responses thus obtained were compared with the common in vitro assays 
like cell migration, proliferation and tube formation. The study demonstrated: 
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 The biosensor responded to the presence of 1000 pg/ml VEGF within 30 min. the 
response from the sensor increased with increasing the exposure time to 10 h. 
 The response of the biosensor to the presence of 100 pg/ml  TNF-α increased with 
increasing the exposure time from 30 min to 3 h. However, further increase in 
exposure time led to a decrease in sensor response. 
 The cell based biosensor sensor was exposed to bFGF and HGF for 1 and 3 h. The 
biosensor responded to the presence of these cytokines. 
 The biosensor was then exposed to different combinations of cytokines (VEGF + 
TNF-α, VEGF + TNF-α + bFGF, VEGF + TNF-α + HGF, VEGF + TNF-α + 
HGF + bFGF) for 1 and 3 h. Increased response was obtained as compared to 
responses to the individual cytokines. Profoundly increased responses were 
obtained when the biosensor was exposed to the combination of all four cytokines. 
 Cell proliferation studies revealed that VEGF, HGF and bFGF enhanced cell 
proliferation while TNF-α inhibited it. Upon incubating HUVECs with both 
VEGF and TNF-α, it was observed that TNF-α downregulated the ability of 
VEGF to stimulate proliferation. Significant increase in mitogenic activity was 
observed upon incubating HUVECs with all the four cytokines. 
 Exposing the wounded HUVEC monolayer to VEGF, HGF, bFGF and TNF-α for 
10 h resulted in significantly increased wound healing as compared to control. 
Incubation of cells with combined cytokines resulted in increased cell migration. 
 Tube formation studies revealed that at the concentration studied, individual 
cytokines produced no significant changes in their ability to induce tube 
formation. However, incubating HUVECs with different combinations of 
cytokines resulted in enhanced tube formation. 
 To compare the permeability assay with the three common angiogenic in vitro 
assays, the responses obtained for each assay were normalized with respect to the 
control values. The comparison demonstrated that the relative change in 
permeability assay in the presence of cytokines as compared to control was far 
greater than the relative change observed in the other assays, especially when the 
cells were exposed to combination of cytokines. 
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Since, the cytokines also modulate permeability across epithelial cells, porcine kidney 
epithelial cell line, LLC-PK1, was seeded across the asymmetric membrane surface of the 
ISE.  The responses of the epithelial cell based biosensor to the presence of VEGF, bFGF, 
HGF and TNF-α were measured and compared with that of endothelial cell based 
biosensor. Moreover, the mechanisms involved behind enhanced permeability were also 
studied. The study demonstrated: 
 
 The epithelial cell based sensor responded to the presence of 1000 pg/ml VEGF, 
2000 pg/ml HGF, 40 pg/ml bFGF and 100 pg/ml TNF-α individually and in 
combination. 
 There was no significant difference in the responses obtained from the HUVEC 
based biosensor and the LLC-PK1 based biosensor to the presence of individual 
cytokines. 
 However, the responses to the combination of cytokines were significantly higher 
in HUVEC based sensor as compared to LLC-PK1 based biosensor. 
 Transmission electron microscopic studies revealed the presence of caveolae like 
structures in the both HUVEC and LLC-PK1 cells treated with all the four 
cytokines for 3 h. However, the increases in density of these transcellular 
structures in response to the treatment with cytokines as compared to the controls 
were more profound in LLC-PK1 cells than HUVECs, indicating increased 
chances of permeability occurring through transcellular pathway in the epithelial 
cells. 
 To determine whether there is increased paracellular permeability, changes in 
percent gap formation were determined in response to cytokine treatment. In the 
case of HUVECs, a significant increase in gap area from 6% in control studies to 
43% in the case of cells treated with all four cytokines was observed. However, 
such a huge increase in gap area was not observed in the case of LLC-PK1 treated 
with different cytokines. 
  A strong positive correlation was observed between gap area and sensor response 
in case of HUVECs indicating the chances of permeability occurring through 
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paracellular route primarily. In the case of LLC-PK1 cells a strong correlation 
was not observed. 
 To elucidate whether the increased response from the sensor is due to increased 
paracellular or transcellular permeability, the HUVEC based biosensor was 
exposed to all four cytokines in the presence of inhibitors of PI3-K and PKC 
(LY294002 and BIM I respectively) individually and in combinations. These 
pathways are known to regulate the cellular junctional proteins and hence the 
paracellular permeability. It was observed that in HUVECs both the pathways 
individually play significant role in inducing paracellular permeability and 
blocking both the pathways simultaneously resulted in a sensor response 
comparable to that obtained for controls, indicating that sensor response is due to 
increased paracellular permeability.  
 The PKC mediated pathway plays a critical role in inducing paracellular 
permeability in LLC-PK1 cells. When both the pathways were blocked, sensor 
response was significantly different from the response obtained from control 
indicating the response from the sensor depends on both induced paracellular and 
transcellular permeability. 
 To determine the effect of the inhibitors BIM I and LY294002 on paracellular gap 
formation, both HUVECs and LLC-PK1 were exposed to all four cytokines in the 
presence of either of the inhibitors or both. For both the cell lines, the gap areas 
decreased significantly in the presence of inhibitors and were comparable to that 
of control. 
 To elucidate the effect of the cytokines on cell-substrate adhesion, cell surface 
area was measured. It was observed that in both the cell lines the cell- substrate 
adhesion increased in the presence of combined cytokines, indicating decrease in 
cell barrier integrity is inversely related to cell-substrate adhesion. 
 
Since angiogenesis play an integral role in cancer progression and the whole cell based 
biosensor can measure permeability, the biosensor was tested to investigate its ability to 
act as a screening tool for cancer. The study demonstrated: 
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 The biosensor responded to the presence of cytokines, individually and in 
combination at the concentrations observed in the serum of healthy individuals. 
 The responses thus obtained were less than the responses obtained for cytokines at 
the concentrations observed in the serum of cancer patients, indicating dose 
dependant response from the sensor. 
 When the responses obtained by exposing the biosensor to the combination of all 
four cytokines at concentrations observed in healthy subjects and cancer patients 
were compared, it was observed that the biosensor was able to distinguish 
between the two concentrations. 
 The responses obtained by exposing the sensor to the cytokines at the two 
different concentrations for 1 h differ significantly. Hence, all the experiments 
with the serum were carried out with an exposure time of 1 h. 
 The responses of the biosensor to the serum from 15 different healthy individuals 
ranged from 0.06 to 0.11 with a mean of about 0.09. 
 When sensor was exposed to serum from different cancer patients, significantly 
higher responses were obtained.  This indicates that the sensor was able to 
distinguish between healthy individuals and cancer patients and the responses 
correlated well with the stages of cancer. 
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Chapter 9 : Future Studies 
 
The present study was focused on extending the application of a whole cell-based 
biosensor towards monitoring physiological toxins and screening cancer. Research can 
further be conducted in several other avenues to extend the application of the biosensor as 
well as to increase its potential for commercial success. Some of the areas where future 
research can be focused are: 
 Studying the effect of anti-angiogenic drugs on sensor response 
 Further studies with  serum of cancer patients 
 Miniaturization of the sensor 
 Studies on stabilization of the sensor as well as increasing the shelf life of the 
sensor 
 
A. Studying the effect of anti-angiogenic drugs on sensor response   
Since uncontrolled angiogenesis is observed in pathological conditions in several diseases 
like cancer, arthritis etc, one approach of treating patients suffering from such diseases 
has been to treat them with anti-angiogenic drugs. While some of the anti-angiogenic 
drugs have already being approved by FDA for anti-cancer therapies, several other drugs 
are now in trial phase. Since, the current study demonstrated that the whole cell based 
biosensor can be used as an assay for measuring angiogenesis, experiments can be 
conducted to investigate the potential of the biosensor to act as a screening tool for 
angiogenic inhibitors. 
 
B. Further studies with the serum of cancer patients 
To investigate the ability of the sensor to act as a prognostic tool, the response of the 
biosensor can be measured by exposing it to serum samples of cancer patients prior and 
after treatment. The efficacy of particular drug for treating cancer can also be investigated. 
 
C. Miniaturization of the sensor 
The advantage of miniaturizing the cell based sensor over the present biosensor lies in the 
fact that it will require less volume of test samples. Requirement of smaller volume of 
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samples becomes critical especially when one deals with body fluids like serum or 
plasma. Moreover, miniaturization can eventually help in construction of array of 
electrodes thus enabling simultaneous detection of analytes. Screen printing the 
electrodes can be a method of construction of planar cell- based sensors.  
 
D. Studies on stabilization of the sensor as well as increasing the shelf life of the 
sensor 
For the biosensor to succeed commercially, one aspect that needs to be taken care of is 
the stabilization of the sensor and extension of its shelf life. One possible way to stabilize 
the cells is to air-dry them and to rehydrate them prior to use. Based on the fact that 
excreted polysaccharides help stabilization of the anhydrophiles in the air-dry state, one 
study has shown that exogenous addition of extracellular components like glycan of 
desiccant tolerant organisms can improve the stability of the mammalian cells in 
desiccated conditions (Bloom et al. 2001). 
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List of Abbreviations 
 
Abbreviation    Description 
 
ANOVA    Analysis of Variance 
ATCC     American Type Culture Collection 
ATP     Adenosine 5’ -triphosphate 
bFGF     Basic Fibroblast Growth Factor 
BIM I     Bisindolylmaleimide I  
BOD     Biological Oxygen Demand 
BSA     Bovine Serum Albumin 
CA-125    Cancer Antigen-125 
CDI     Carbonyldiimidazole 
CEA     Carcinoembryonic Antigen 
CTA     Cellulose Triacetate 
CTC     Circulating Tumor Cells 
DIUF     Deionized Ultrafiltered 
DMSO     Dimethylsiloxane 
DNA     Deoxyribonucleic Acid 
EC     Endothelial Cell 
ECIS     Electric Cell-Substrate Impedance Sensor 
ECM     Extracellular Matrix 
EDTA     Ethylenediaminetetraacetic Acid 
EGM     Endothelial Growth Media 
ELISA     Enzyme-Linked Immunosorbent Assay 
EMF     Electromotive Force 
FBS     Fetal Bovine Serum 
FOBT     Fecal Occult Blood Test 
GOD     Glucose Oxidase 
GRGDS    Glycine-Arginine-Glycine-Aspartic Acid-Serine 
HBSS     HEPES Buffered Saline Solution 
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HGF     Hepatocyte Growth Factor 
HUVECs    Human Umbilical Vein Endothelial Cells 
ISE     Ion Selective Electrode 
IUPAC    International Union of Pure and Applied Chemistry 
KTClPB    Potassiumtetrakis (4-chlorophenyl) borate 
LOH     Loss of Heterozygosity 
MI     Microsatellite Instability 
NASA     National Aeronautics and Space Administration 
NO     Nitric Oxide 
NOS     Nitric Oxide Synthase 
NPOE     Nitrophenyl Octyl Ether 
Pap Test    Papanicolaou Test 
PBS     Phosphate Buffer Saline 
PSA     Prostate Specific Antigen 
PI3-K     Phosphoinositide 3-Kinase 
PKC     Protein Kinase C 
QCM     Quartz Crystal Microbalance 
SEM     Standard Error of the Mean 
SPR     Surface Plasmon Resonance 
TNF- α    Tumor Necrosis Factor-α 
TNS     Trypsin Neutralizing Solution 
Tris     Tris(hydroxymethyl) aminomethane 
VEGF     Vascular Endothelial Growth Factor 
VVO’s     Vesiculo- Vacuolar Organlles 
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